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Abstract
The dissertation thesis focuses on the problematic of biliary stents functional coating, which may 
play an essential role in the life prolongation of cancer patients with bile duct types of cancer 
tumors. The developed coating represents a polymeric nanocomposite thin film prepared via in-
situ polymerization, re-polymerization and extrusion methods. 
Prepared number of samples with different types of antimicrobial agents, clay particles and 
polymeric matrices is characterized by X-Ray diffraction, FT Infrared Spectroscopy, Differential 
scanning calorimetry, Scanning Electron and Atomic Force Microscopy techniques as well as tested 
on microbial activity via special microbiological techniques. The charecterization provides the data 
about stability, morphology and structure of the developed materials. Several “in-body simulation” 
experiments are performed such as bile salts simulation, real-time liquid flow biofilm growing and 
visualization of the effect of the selected nanocomposite sample on the growth. The results show 
the actual antimicrobial functionality of the developed materials in case of ciclopirox olamine, less 
in case of imidazole and clotrimazole antimicrobial agents. Molecular modeling was used to prove 
the thermodynamical stability, it showed that the system gets more stable with greater 
antitumoral drug amount. 
Molecular modeling was used to demonstrate the thermodynamic stability of drug system, it 
showed that the system becomes more stable with more antitumoral drug. An attempt to 
experimentally prepare an antitumoral polymeric nanocomposite was made.
Keywords: Nanocomposite, Biofilm, Polymeric matrix, Biliary stents, Clay minerals, 
Nanoparticles, Thin film, Antimicrobial agent, Cancer treatment
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Abstrakt
Disertační práce se zaměřuje na problematiku funkčního povlaku žlučových stentů, který může hrát 
zásadní roli v prodloužení života pacientů s rakovinou s rakovinou žlučových cest. Vyvinutý povlak 
představuje polymerní nanokompozitní tenký film připravený metodami in-situ polymerace, re-
polymerace a extruze.
Připravené vzorky s různými typy antimikrobiálních látek na jílových částicích zakomponované do 
tří různých polymerních matric je charakterizován rentgenovou difrakcí, FT infračervenou 
spektroskopií, diferenciální skenovací kalorimetrií, skenovací elektronovou mikroskopií a 
mikroskopií atomárních sil. Vzorky jsou dále testovanými na mikrobiální aktivitu pomocí speciálních 
mikrobiologických technik. Vyhodnocením výsledků analýz a testů jsme získali údaje o stabilitě, 
morfologii a struktuře vyvinutých materiálů. Dále byly uskutečněny testy in vitro, jako je simulace 
žlučových solí, růst biofilmu v tekutém toku v reálném čase a vizualizace účinku vybraného vzorku 
nanokompozitu na růst. Výsledky ukazují skutečnou antimikrobiální funkčnost vyvinutých materiálů 
v případě ciclopirox olaminu, méně v případě imidazolových a klotrimazolových antimikrobiálních 
látek. 
Molekulární modelování bylo použito k prokázání termodynamické stability polymerního systému s 
léčivem, ukázalo se, že systém se stává stabilnějším s větším množstvím protinádorového léčiva. Byl 
proveden pokus experimentálně připravit protinádorový polymerní nanokompozit.
Klíčová slova: Nanokompozit, Biofilm, Polymerní matrice, Biliární stenty, Jílové minerály, 
Nanočástice, Tenký film, Antimikrobiální látka, Léčba rakoviny
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1. INTRODUCTION
“Solve et coagula”
The materials science in field of medicine has made humongous progress in last few decades.  The 
innovation in advanced materials and design of devices used for surgery and prosthetics is helping 
to extend human life and improve quality of patient’s life.     
The main risk areas of the surgery and following recovery from the illness are the infection. The 
infection can be caused via several life endangering bacterial strains and some yeast species. 
Bacteria and the risk of infection is a significant concern for medical plastic components inserted 
into the body.  Applications of greatest concern are those exposed to bodily fluid for extended 
periods of time, including but not limited to catheters, wound dressings, hospital bedding, surgical 
drapes, and hospital gowns. The risk of infection is particularly high for those tubes and 
components that are left in place for three or more days (i.e. in-dwelling catheters).
In this case, handling and exposure of these devices can influence time of onset and severity of 
infection.  Infections often occur at incision points, where enter the blood vessel and bacteria is 
introduced into blood stream.
The general mechanism of infection related to in-dwelling polymers can be summarized as follows:  
Free floating microorganisms attach to the plastic surface. Colonies of bacteria grow and 
permanently anchor to plastic surface.  A biofilm formation results as colonies grow and mature.  
Infection occurs when biofilm detaches from plastic substrate.
Antimicrobial technologies using both silver and polymer-based solutions are designed to fight 
infection and prevent the development of bacteria on contact surfaces. Formulations are custom 
developed to achieve specific application requirements.
Biofilms are of great importance in control of healthcare associated and other infections. This is 
not only due to their ability to act as a safe-haven for those microorganisms that are of public 
health significance, but also due to their inherent tolerance of and ‘resistance’ to antimicrobials. 
The diagnosing of a biofilm infection represents an area of grave concern significantly easier on 
abiotic surfaces following removal of a medical device than on biotic surfaces. For example, 
evidencing a biofilm within a chronic wound is complex and presently there is no ‘gold standard’ 
for that (Percival et al., 1999; Percival et al., 2010; Percival et al., 2015).
The main issue for successful and long-term elimination of the bacterial infection connected to the 
biofilm creation, is careful selection of materials of the medical device. Recent development of 
advanced materials is being more and more related to nanotechnology options. Utilization of 
materials which contains functional nanoparticles or have nanostructured surface/bulk is getting 
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very advantageous for many applications in medicine. As the wide range of materials used for 
medical devices are either metallic of polymeric, the main interest will be focused in improving of 
those materials. 
In case of metallic devices, the research and discussion are heading to the modification of surfaces 
with appropriate coating. The coating should have except functionality very good adhesion to the 
metal surface material. 
The polymeric surface will have more options for modification. Except attaching or depositing 
other functional layer we can play with base material itself to modify upper layer of the bulk.
To mitigate the infections associated with the implanted devices, a variety of antimicrobial device 
coatings have been developed with the goal of inhibiting the growth of biofilms on the devices 
both with and without drugs. Antimicrobial device coatings have dramatically evolved over the 
past couple of years. While early technologies focused on diffusion-based antibiotic-eluting 
coatings that provide short-term antimicrobial therapy, recent technologies have shifted their 
focus to coatings with more long-term antibiotic-eluting capabilities and materials that show 
intrinsic antimicrobial activity. The growing trend in the annual number of scientific journal 
publications on antimicrobial coatings over the past 17 years. Specifically, from 1997 to 2014, there 
has been a nearly 30-fold increase in the number of articles annually published on antimicrobial 
coatings, demonstrating the large number of innovations that have recently been developed in the 
field. In particular, the increase in publications over the past five years can be partially attributed to 
the legislative changes of the Patient Protection and Affordable Care Act (2010) (Cyphert et al., 
2017).
 THE WORK AIMS
The presented work is focused on materials suitable for medical applications, where the rapidly 
growing microbial biofilm is one of the serious dangers for health and life of a human. Since the 
range of the materials and applications in the field of prosthetics inserted in the body is large, this  
work will specialize only on one type of medical devices which are gastronentheorological stents 
applicable in case of damaged bile duct. 
The research in this field will focus on study and optimization of polymeric stent material in respect 
to the conditions in the body.
The polymeric  stent with antimicrobial/antitumoral  filler  may prolong the lifetime of  the stent 
inside the body and therefore intense the treatment (Fig.1). 
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Figure 1. The schematic concept of the stent coating with drug elimination.
The partial goals of the work are:
 Molecular modeling of selected interaction
 Based on the known clinical facts and literature recherche select optimal basic materials and 
modifying compounds for experimental part
 Laboratory synthesis of functional antimicrobial materials suitable for incorporation to the 
polymeric matrix
 Laboratory preparation of polymeric nanocomposite
 Nanocomposite testing for stability
 Antimicrobial testing of selected nanocomposite
 Finding the most effective combinations of contents in nanocomposites
 Testing in-vivo
The  experimental part of work presents the preparation and optimization of the polymeric film 
with  antibacterial  compounds.  The  formation  and  behavior  of  biofilms  are  tested  via  special  
microbiological methods.
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2. THEORETICAL PART 
The theoretical part first briefly explains the problematics of microbial biofilm along with related 
medical aspects. Then it continues in description of the materials selected for the research and 
shows the preparation methods of recently used polymeric nanocomposites. The chapter ends by 
showing the  mechanisms of  action of  antimicrobial  drugs,  methods  for  further  elimination of 
microbial film and points at usage of antitumoral drugs in chemotherapy. 
2.1  BIOFILM ALARM
The  modern  society  is  focused  on  increasing  the  level  of  life  and  its  quality.  Although  the 
population of the planet is rapidly growing and in current moment there is almost 8 billions of 
people,  we  all  want  to  be  healthy  and  have  a  chance  to  survive  all  possible  and  impossible  
conditions. As the humanity develops and adapts to a new reality, so do the bacterial strains and  
other living beings. The microorganisms are getting resistant to medicines and the consequences 
from it are dangerous for the whole of society. 
Antibiotics were first synthesized in the beginning of 20th century, the very first one was called  
Arsphenamine and was used against syphilis  (Gibaud et al., 2010). For more than a century the 
pharmaceutical  industry  was  actively  developing  the  treatments  against  all  possible  diseases 
associated with bacterial strains. Millions of people’s lives have been saved, many deadly infections 
have been beaten. Nowadays, antimicrobials can be found almost everywhere, even in the chicken 
bought for dinner in supermarket.
The World Health Organization claims that the excessive usage of  antimicrobial  agents will  be 
reduced to a reasonable minimum (O’Neill, 2016).
By 2050 the deaths from resistant bacterial infections are expected to overcome the lethal cancer 
cases (Fig.2). 
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Figure 2. Antimicrobial resistance caused deaths compared to other major death causes (Cyphert 
et al. 2017).
BIOFILM DEFINITION
In  comparison  to  higher  life  forms  microorganisms  can  be  seen  as  simple  ones.  But  the  
investigations show their incredible ability to develop into complex systems to have a chance to 
survive  different  stresses  (temperatures,  UV-light  etc.).  These  complex  systems  are  known  as 
bacterial biofilms. Opposite from laboratory conditions when the bacteria are isolated on specific  
media,  in  nature  they  are  surviving  mainly  by  attaching  to  and  developing  on  many  kinds  of 
surfaces including human tissues and medical devices such as catheters and stents. It is considered 
a reason of numerous diseases like pneumonia and many tract and bloodstream infections. As a 
consequence,  the  complexity  of  biofilm  brings  lower  susceptibility  to  antimicrobial  agents  if 
compared with planktonic organisms. When a medical device is colonized by a biofilm there is 
often a need of its removal and replacement operation (O’Toole et al., 2000; Olson et al., 2002).
Biofilms grow in several stages shown on Fig.3.
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Figure 3. Stages of biofilm development. 1. Initial attachment 2. Irreversible attachment 3. 
Maturation I  4. Maturation II  5. Dispersion (O’Toole, 2000).
A biofilm can be defined as the extracellular polymers produced by microcolonies attached to the 
surface. The extracellular polymeric substance (EPS) contains polysaccharides and is very hydrated. 
The  structure  is  heterogeneous  and contains  channels  for  nutrient  and oxygen transportation 
(Lewandowski, 2000). It can be called “slime”, which is causing so much difficulties with treatment.  
Infiltration of this slime is problematic for many antibiotics and chemicals, furthermore, on the 
slime’s  surface  are  the  electrical  charges  which  can  create  a  barrier  for  antimicrobials.  Also,  
antibiotics are efficient mostly on actively growing cells but the cells hidden behind the biofilm are 
slow  because  of  oxygen  and  nutrient  starvation,  therefore  they  have  lower  susceptibility  to 
antibiotics. 
Obviously, it is not that simple to get rid of biofilms on surfaces, but there are several options. For 
example, removal of implant can help, if  the biofilm haven’t spread to a living tissue (Donlan, 
2001).  Other  methods  include  different  coatings  for  implants  such  as  silver  layers,  different 
antimicrobial drugs, nanoparticles or nanocomposites.
The severity of the infection depends upon the type of bacteria or fungi involved as well as the 
maturity of  the biofilm they may develop upon bacterial/fungal  colonization on the device.  In 
particular,  Gram-positive Staphylococcus  aureus (S.  aureus)  and epidermidis (S.  epidermidis)  are 
some of the most common bacterial strains responsible for forming biofilms on the devices (Naber, 
17
2009). For fungal biofilms, Candida albicans (C. albicans) is the most prevalent. Once the biofilms 
are established, they can be very difficult to treat with conventional antibiotic treatments since the 
bacteria  in  the  biofilm  are  metabolically  inactive,  rendering  the  biofilms  less  responsive  to 
antibiotics (Cohen et al.,  2013). Under these circumstances,  the infected device often fails  and 
must be removed from the patient to eradicate the infection. Therefore, the goal of antimicrobial  
device coatings is to prevent the infection, since treatment after infection occurs is challenging. 
While only a small percentage of patients develop infections, the cost of treating these infections 
surpasses $11 billion every year with nearly 2 million infection cases annually (Schierholz et al.,  
2001).
2.2 MEDICAL ISSUES – BILIARY STENTS
2.2.1 THE BILE DUCT
The biliary  tract,  (biliary  tree or  biliary  system) includes  the liver,  gall  bladder  and bile  ducts,  
altogether they are able to make, store and secrete bile (Fig.4). Bile consists of water, electrolytes, 
bile acids, cholesterol, phospholipids and conjugated bilirubin. Some components are synthesized 
by liver cells (hepatocytes), the rest liver extracts from the blood.
Figure 4. Biliary system scheme.
2.2.2  BILE AND ITS FUNCTION 
Bile is made in the liver and stored in the gallbladder. The system of bile fluids includes water (97%), fats such 
as cholesterol, lecithin, phospholipids and fatty acids (0.51%), bile salts (0.7%), bilirubin (0.2%) and some  
inorganic salts  (Barret et al., 2012). When lipids enter the small intestines, this triggers the release of bile. A  
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bile acid has two sides, a hydrophilic side and a hydrophobic side (Fig.5). To allow lipids to travel in an 
aqueous environment, the hydrophobic side binds to the lipid and surrounds it, creating an emulsion. Bile 
aids the digestive process by making it  easier  for  enzymes to digest  the fat,  but is  necessary for  lipid  
absorption. After bile is absorbed and utilized, it can be recycled by the body and reused. Liver secretes the 
bile into small ducts which form the common hepatic duct. 
Figure 5. Lipid-bile acid interaction.
The bile duct is long tube-like structure that connects the liver to the intestine. The liver makes bile 
that is required for the digestion of food. The bile from the liver is transported to the intestine by  
the bile duct. It contains a mix of products such as bilirubin, cholesterol, and bile acids and salts.
The top half of the bile duct is associated with the liver while the bottom half of the bile duct is  
associated with the pancreas through which it passes on its way to the intestine. It opens in the 
part of the intestine called the duodenum into a structure called the Ampulla.
A variety of diseases can affect the bile ducts. All block the bile ducts in some way, which is why  
the various diseases cause similar symptoms.
Less  common causes  of  blockages  include cancers  of  the bile  duct  (cholangiocarcinomas)  and 
strictures (scars that narrow the ducts after infection, surgery or inflammation). 
Jaundice is commonly caused by conditions such as pancreatic cancer caused by blockage of the 
bile duct passing through the cancerous portion of the pancreas, bile duct cancer, blockage by a 
stone in patients with gallstones and from scarring after injury to the bile duct during gallbladder 
removal. The disease allows the skin and eyes to become yellow from the accumulated bile in the  
blood. This condition also causes severe itchiness.
Other bile duct diseases are uncommon, and include primary sclerosing cholangitis and primary 
biliary  cirrhosis.  Typically  diagnosed  in  mid-adulthood,  these  conditions  create  ongoing 
inflammation  in  the  bile  duct  walls,  which  can  narrow and  scar  the  walls.  Primary  sclerosing 
cholangitis  is  more  common  in  people  with  inflammatory  bowel  disease  (ulcerative  colitis  or  
Crohn's  disease).  Primary  biliary  cirrhosis  is  more  common  in  women  (Poupon,  2010).  It  is 
sometimes  associated  with  autoimmune  diseases  such  as  Sjögren's  syndrome,  thyroiditis, 
scleroderma or rheumatoid arthritis. 
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Biliary atresia is a rare form of bile duct blockage that occurs in some infants two weeks to six 
weeks after birth, a time when the bile ducts have not completed their development normally.
The chronic conditions of primary sclerosing cholangitis, primary biliary cirrhosis and biliary atresia 
can result in inflammation and scarring of the liver, a condition known as cirrhosis.
Certain parasite infections mostly common in Southeast Asia (Clonorchis sinensis and Opisthorchis  
viverrini, also known as Chinese liver fluke) are associated with a higher risk of bile duct diseases.
2.2.3  BILIARY STENT APPLICATION
Stent is a short narrow metal or plastic tube often in the form of a mesh that is inserted into the 
lumen of an anatomical vessel (such as an artery or a bile duct) especially to keep a previously 
blocked passageway open.
Recent years many types of stents have been investigated, all have advantages and disadvantages 
which have to be discussed.
Biliary  and  pancreatic  plastic  or  metal  stents  are  used  primarily  to  establish  patency  of  an 
obstructed bile duct or main pancreatic duct but may also be used to treat biliary or pancreatic 
leaks, cholecystitis, large non-removable common bile duct stones, pancreatic fluid collections and 
to  prevent  post  endoscopic  retrograde  cholangiopancreatography  (ERCP)  pancreatitis 
(Mangiavillano, 2015). This has become established as a treatment to resolve obstructive jaundice 
by  a  non-surgical  approach.  As  this  technique  allows  the  relief  of  preoperative  acute  biliary 
obstruction, it is useful for stabilizing patients before surgery and enhancing their quality of life by 
enabling internal  drainage in those who are not eligible for surgery.  Although it  is a beneficial  
method of treatment, it also can cause some further complications.
Biliary stenting is an effective solution of relieving obstruction, and is the preferred method of  
alleviating patients with malignancy (Barkay et al., 2013)  as well as in benign conditions such as 
biliary fistulas or benign biliary strictures (Dumonceau et al., 2011). 
As  (Coté et al., 2016) said in their research “among patients with benign biliary strictures of 6 mm  
or larger in whom the covered metallic stent would not overlap the cystic duct, cSEMS (covered  
self-expanding metallic  stent)  were  not  inferior  to multiple  plastic stents  in  achieving stricture  
resolution after no more than 12 months of endoscopic therapy”. 
The efficacy  of  both types  of  biliary  stents  is  high  and frequent.  Plastic  stents  are  of  interest 
because of economic reasons, they are at least 10 times cheaper than SEMSs. Developed plastic 
stents could not only help in expanding of vessels and unblocking the pathways for liquids but also 
to  prevent  occurring  of  various  complications  and to  increase the efficacy  of  treatment  itself. 
SEMSs are associated with a statistically significantly lower occlusion rate, less therapeutic failure, 
less need for reintervention, and lower cholangitis incidence (Sawas et al., 2015).
On the other hand, an important problem is the negative effect of metal ions or fretting debris,  
which can be released from the stainless steel implant devices because of corrosion, wear or other 
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reasons. Nickel and chromium are known as potentially harmful elements in the medical stainless 
steel. Nickel ions act as the allergens, which may cause cutaneous inflammations such as swelling, 
reddening, eczema and itching on skins, and may also lead to allergy reactions, teratogenicity and  
carcinogenicity in human body (Yang et al., 2010). The optimization of the metal-based stents, as  
well as plastic-based, is developing rapidly and there are already some solutions for the reduction 
of nickel release and increasing of biocompatability (Gill et al., 2015).
 In comparison with metallic stents according to recent publications there is a higher probability of  
different stent failures in plastic-based stents (Table 1).
Stent failure is associated with recurrent morbidity, and often necessitates repeat endoscopy with 
stent  retrieval  and  replacement.  These  procedures  carry  an  increased  risk  for  procedural 
complications such as pancreatitis, and can result in additional hospital admissions (Shatzel, 2016).
Table 1. Current stent failure rates.
Stent type Stent failure rates in malignant obstruction
Plastic stents 30%-70%
Self expanding metal stents 19%-46%
Stent  failure  can  be  stratified  into  four  primary  etiologies:  Internal  stent  failure  from  biliary  
clogging,  external  failure  caused by  tumour  ingrowth or  overgrowth of  excessive  epithelial  or  
malignant cells, and stent migration. The incidence of each type of failure in malignant obstruction 
has been documented in several small prospective trials (Table 2).
Table 2. Causes of stent failure.
Causes of stent failure Percent of total failures
Tumor ingrowth 66%-68%
Epithelial ingrowth -
Biliary clogging 17%-21%
Tumor overgrowth 2%-11%
Stent migration 0%-4%
Although the biliary plastic stents were first introduced in 1979 and the very first coronary stent 
was implanted in 1986 (Serruys et al., 2006), the further research on stents didn’t go too far. As a 
solution to prevent the failures of implanted biliary stents the usage of several drugs has been 
performed. None of them nowadays are ideally fitting the conditions of the biliary environment. 
Ideal agents to incorporate into the stent exterior would help to effectively inhibit the growth of 
malignant  pancreaticobilary  cells,  retard  the  proliferation  of  biliary  epithelial  hyperplasia  and 
display favorable histologic changes when exposed to biliary epithelium, without necrosis or risk of 
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biliary perforation (Shatzel, 2016).
There  are  two  ways  to  place  a  bile  duct  stent:  ERCP  (endoscopic  retrograde 
cholangiopancreatography) and PTC (percutaneous transhepatic cholangiography).
Endoscopic treatment includes radial dilation with balloon dilators followed by the placement of 
post-stricture stents that must be maintained for at least three months. The control for evaluation 
of  biliary  duct  patency  may  be  performed  through  magnetic  resonance  cholangiography  or 
endoscopic cholangiography. This treatment is less invasive than surgery with success rates ranging 
from 70% to  80% (Vitale  et  al.,  2008).  In  general,  80-90% of  biliary  strictures  can  be  treated  
through endoscopy.  The predictors  for  endoscopic  treatment failure  include lesions  above the 
hilum, long stenoses, late postoperative presentation (more than 3 months), anatomic variations of 
the upper gastrointestinal tract or of the biliary ducts, and clinical conditions of patients that affect  
the safety of prolonged sedation or general anesthesia (Artifon et al., 2012). 
The main disadvantage of plastic stents is their limited diameter. This is set by the working channel 
in the duodenoscope, which prevents use of plastic stents with an outer diameter of more than 
~4mm or 12 Fr (French scale or French gauge system commonly used to measure the size of a 
catheter) (Raijman, 2003). This can be a major issue for patients who require long-term placement 
of a stent. Stents with a larger diameter have longer patency because it takes longer for the inner 
cavity to fill  with foreign substances (Speer et al.,  1988). However, it is impossible to endlessly 
extend the diameter of  the working channel of an endoscope due to its design,  and thus the  
maximum outer diameter of a plastic stent is 11.5 Fr at most. Then 10 Fr plastic stents require a  
duodenoscope  with  an  accessory  channel  of  3.7  mm,  and  11.5  Fr  plastic  stents  require  a 
duodenoscope with an accessory  channel  of  4.2  mm (Pfau  et  al.,  2013).  According  to  several 
studies no major difference in the outcome between 10- and 11.5-Fr stents was found, and the 
mean duration of stent patency was 3 to 6 months (Kadakia et al., 1992). Despite the opinions that  
the composition of the plastic stent might affect its patency, some previous studies have suggested 
that patency was not significantly affected by composition (Teflon, polyurethane, or polyethylene) 
or shape (Terruzzi et al., 2000; England, 2000).
TREATMENTS FOR BILE DUCT CANCER
It is not usually possible to cure bile duct cancer because it is often diagnosed after it has grown 
and spread. But even in these cases, the treatment can help to control the symptoms for months 
or years. The main treatments for bile duct cancer are:
- surgery to remove the affected area – this is only suitable for a small number of people, but could  
get rid of the cancer completely
- inserting a hollow tube (stent) into the bile duct to stop it becoming blocked – this can help relieve  
symptoms such as jaundice (Fig.6)
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- chemotherapy – where medication is given to stop the cancer cells growing and to relieve your 
symptoms
- radiotherapy – where a beam of radiation is carefully aimed at the cancer cells to stop them 
growing and to relieve your symptoms
Figure 6. How the bile duct polymeric stent may look like.
2.2.4 BACTERIAL STRAINS IN BIOFILMS 
The popular theory is that bacterial biofilm and biliary sludge both play major roles, along with the  
extent of bacterial infection and duodenobiliary reflux of dietary fiber (Raijman, 2003; Leung et al.,  
2000).
The regular biliary sludge is different from cholesterol-rich sludge, which is related to gallstone 
formation. The biliary sludge that causes stent occlusion mainly consists  of crystals  of calcium 
bilirubinate and calcium palmitate produced by bacterial enzymes (Leung et al., 1988; Groen et al.,  
1987; Guaglianone et al., 2010). It is also known that several types of proteins (such as fibronectin, 
vitronectin, laminin, fibrin, and collagen), which are derived from bacteria of a specific origin but 
are not naturally present in bile, form a film, making the bacteria more adhesive and also work 
with the bacteria to produce biliary sludge (Yu et al., 1996; An et al., 1998). The development of a  
biofilm that occurs because of attachment of these proteins onto the inner surface of a stent is  
known to play an important role in the initiation of sludge accumulation.
Microorganisms isolated from occluded biliary stents include anaerobic bacterial species,  fungi,  
and aerobic  bacterial  species.  As  aerobic  species  there  are  most  commonly the gram-positive 
Enterococcus species, and gram-negative Escherichia coli and Klebsiella species, among anaerobic 
bacteria - Clostridium species (Fig.7).
23
Figure 7. Spectrum of microorganisms isolated from biliary stents (Lübbert et al., 2016)
Surprisingly,  antibiotics,  although  there  is  a  theoretical  possibility  for  decreasing  bacterial 
colonization,  didn’t  show  any  effect  in  decreasing  internal  failure  rates  when  given  both 
systemically  or  locally  through  drug  elution  (Lee  et  al.,  2016).  As  bacterial  colonization  is 
considered to be the most important cause of biliary plastic stent occlusion, in vitro and in vivo 
studies have been conducted with various antibiotics; however, none were found to prolong stent 
patency (Donelli et al., 2007). There were several trials to induce synergistic effects by combining 
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antibiotics with choleretic agents such as ursodeoxycholic acid or terpene. However, the review of 
Galandi et al.  including a meta-analysis of 5 randomized trials reported no significant effect on 
stent patency or mortality rate (Galandi et al., 2002).
The process of biofilm formation in general is very complex (obstruction of biliary stents is more 
complex and involves not only bacteria and their products but bilirubin complexes, cholesterol  
complexes and ingrowth of tissue) (Fig.8). Biofilms are multicellular, three-dimensional aggregates 
that form on surfaces in both nature and the clinic. The ability to form biofilms in a variety of 
environments  is  a  common defensive  characteristic  of  several  bacteria.  The  proximity  of  cells  
within  the  biofilm  creates  the  opportunity  for  coordinated  behaviors  through  cell-to-cell  
communication using a spectrum of diffusible signals, the most well documented being the so-
called “quorum sensing” (Miller et al., 2001).
Chemical–physical conditions created by the biofilm make the bacteria up to 1000 times more 
resistant  to  antimicrobials  than  the  planktonic  cells;  thus,  bacterial  biofilms  sustain  chronic 
infections, especially because they show augmented tolerance to antibiotics. 
Figure  8.  Presence  of  biofilm  formation  on  a  biliary  polyethylene  stent  in  a  62-year-old  liver  
transplant  recipient  with  anastomotic  bile  duct  stenosis,  visualized  by  fluorescence  in  situ 
hybridization  (FISH).  Using  cultures,  Enteroccus  faecalis and  Escherichia  coli were  detected 
(Lübbert, 2016).
2.3 POLYMERIC NANOCOMPOSITES FOR BIOFILM ELIMINATION
Many of the coatings rely on the encapsulation of various antibiotics or antifungal drugs to prevent 
device infection by locally delivering the drug. While there are many benefits to locally delivering 
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the drug to prevent device infection, these coatings have the potential to cause off target long-
term toxicities, and can lead to the development of drug-resistant bacteria when the antibiotic is 
delivered at a subinhibitory dose and has a limited window of activity.
A number of successful polymer-based coatings have been developed using different quaternary 
ammonium  salts  and  cationic  polymers.  These  coatings  primarily  function  through  either  a 
disruption of the bacterial membrane using cationic charges or hydrophobic interactions repelling 
the adherence of bacteria. The benefit of these coatings is that they are primarily non-leaching 
coatings and therefore demonstrate long-term intrinsic antibacterial activity, are biocompatible, 
and do not cause any significant cytotoxicity.
 
Figure 9. Scheme of proposed functionality of polymeric coating.
The focus is on polymeric antibacterial nanocomposite coating of inner bulk material of polymeric 
stent (Fig.9). Since we decided to tailor and develop functional sustainable coating the preference 
was given to biodegradable polymers as a matrix for nanocomposite film, because we believe that 
via  gradual  degradation of  matrix  the constant  functionality  of  nanocomposite  coating can be 
assured.
2.3.1 POLYMERIC NANOCOMPOSITES WITH LAYERED FILLERS
In polymer-inorganic nanocomposites, the synthetic routes are usually related to the conditions for 
polymerization. The polymerization conditions or technologies for the nanocomposites are usually 
the  same  as  those  for  the  pristine.  An  important  aspect  of  preparing  nanocomposites  is  the 
particle  surface  treatment  as  described  in  other  sections.  A  primary  mechanism  in 
compatibilization  of  phase  separated  polymer  blends  involves  lowering  the  interfacial  tension 
between the phases and preventing coalescence of the particles during melt processing (Paul et 
al., 2008). The function of surfactant can be explained by its characteristic structure: surfactants  
usually have a structural group that has very little attraction for the solvent, known as a lyophobic 
group, and a group that has strong attraction for the solvent, called the lyophilic group. This is  
known  as  an  amphipathic  structure.  Often  used  are  deposition reaction  modification,  surface 
chemical modification, and mechanical force chemical modification, modification by high energy 
and modification by  polymer  surface  grafting  and  intercalation.  These  modifications  solve  the 
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problems of  heterogeneous  aggregation.  The  interactions between the reacting groups  of  the 
polymer and the nanoparticles depend on the chemical structure of the polymer, the nanoparticle 
surface charge:
- Covalent bonds: carboxyl groups, sulfonating groups, amide or amine groups can form a covalent 
bond with, e.g., hydroxyl, groups on the nanoparticles.
-  Ionic bonds:  a chemical  bond formed by coulombic attraction between positive and negative 
charges. Generally, the selected polymer chains and nanoparticles have opposite charges, and the 
ionic interaction between them stabilizes the nanocomposites systems.
- Chiral bonds: organic matrices usually have pair electrons, which have chiral interactions with 
empty electron orbitals through which a chemical interaction occur. The chiral interaction effect is 
used to prepare nanocomposites by in situ polymerization.
- Affinity effect: The surface affinity of nanoparticles for groups in polymer chains forms a strong 
interaction. This affinity ensures the homogenous dispersion of nanoparticles into the polymer 
matrix or their combinations.
Nanoparticles can be synthesized from a variety of materials. Owing to their high specific surface 
area  and low surface energy,  nanoparticles  are  not  stable  in  ambient  circumstances,  and it  is 
suitable to incorporate them in certain kinds of materials. Reverse micelles, glass, zeolites, and 
polymers can be used as the substrate to prepare composite materials containing nanoparticles. 
This substrate not only can prevent the nanoparticles from aggregation, but also can accurately 
control their size, shape and surface structure (Yang et al., 2009).
In  general,  polymer/layered  silicate  nanocomposites  are  of  three  different  types,  namely 
intercalated nanocomposites, for which insertion of polymer chains into a layered silicate structure 
occurs  in  a  crystallographically  regular  fashion,  with  a  repeat  distance  of  few  nanometers, 
regardless of polymer to clay ratio, flocculated nanocomposites, for which intercalated and stacked 
silicate layers flocculated to some extent due to the hydroxylated edge–edge interactions of the 
silicate layers, and exfoliated nanocomposites, for which the individual silicate layers are separated 
in the polymer matrix by average distances that depend only on the clay loading (Sinha Ray et al.,  
2003).
Nowadays  utilization of  clays  in  nanocomposites  is  very  in  demand.  Natural  clay  particles  are 
hydrophilic  and are  sensitive to mechanical–chemical  treatments.  The commonly used layered 
silicates for the preparation of polymer/layered silicate (PLS) nanocomposites belong to family of  
2:1 layered silicates or phyllosilicates. Their crystal structure consists of layers made up of two 
tetrahedrally  coordinated  silicon  atoms  fused  to  an  edge-shared  octahedral  sheet  of  either 
aluminum or magnesium hydroxide (Fig, 10).
The layer thickness is around 1 nm, and the lateral dimensions of these layers may vary from 30 
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nm to several microns or larger, depending on the particular layered silicate. Stacking of the layers 
leads to a regular van der Waals gap between the layers called the interlayer or gallery. Polymeric 
nanocomposites  containing  homogenously  dispersed  clay  platelets  present  material  with 
enhanced  mechanical,  chemical,  and  physical  properties  in  comparison  with  conventional 
polymeric material. However, the fabrication of such nanocomposites still brings in basic obstacles. 
Therefore, fundamental knowledge of clay minerals and behavior in various chemical and physical 
environments will be here presented.
The  pretreatment  of  clays  for  following  usage  in  nanocomposites  represents  several  specific 
techniques for  example,  exfoliation and delamination,  intercalation with inorganic  and organic 
species, and/or leaching (Sinha Ray et al., 2003; Pavlidou et al., 2008; Sinha Ray, 2003).
Figure 10. Model of 2:1 layered phyllosilicate.
The most popular clay minerals are smectites for long time. Especially montmorillonite is keeping 
its position as nanofiller for polymeric matrices, modified sorbent or carrier for other inorganic 
nanoparticles.  Since,  in  their  pristine  state  layered  silicates  are  only  miscible  with  hydrophilic  
polymers, such as poly(ethylene oxide) and poly(vinyl alcohol), in order to render them miscible 
with other polymers, one must exchange the alkali counter-ions with a cationic-organic surfactant 
(Šupová et al.,  2011).  The organic  cations lower the surface energy of  the silicate surface and 
improve wetting with the polymer matrix. Moreover, the long organic chains of surfactants, with 
positively  charged ends,  are  anchored to the surface of  the negatively  charged silicate  layers, 
resulting in an increase of the gallery height.
Two characteristics of layered silicates play an important role in the creation of nanocomposites:  
the first is the ability of silicate sheets to disperse into individual layers, and the second is the  
possibility  to modify  their  surface chemistry  through ion exchange  reactions with organic  and 
inorganic cations. The simple mixing of polymer and layered silicates does not always result in the 
generation of a nanocomposite, as this usually leads to dispersion of stacked sheets. This failure is 
due to the weak interactions between the polymer and the inorganic component. The surfactant 
cations  lower  the  surface  energy  of  the  inorganic  reinforcement,  improve  the  wetting 
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characteristics of the polymer matrix, and result in larger interlayer spacing (Fig. 11). Additionally, 
the surfactant cations can provide functional groups that react with the polymer matrix or, in some 
cases, can initiate the polymerisation of monomers to form the polymer in-situ (Choudalakis et al.,  
2011); Bitinis et al., 2011).
Figure 11. Silicate layer modification  (Takahashi et al., 2011).
Polymer nanocomposites containing layered silicates have been considered as a new generation of 
composite materials due to their expected unique properties attributed to the high aspect ratio of 
the inorganic platelets. Nevertheless, addition of layered silicates to polyolefins mostly results in 
phase  separated  systems  because  of  the  incompatibility  of  the  silicates  with  the  non-polar 
polyolefins.  Functional  compatibilizers  are  required  to  enhance  the  interactions  and  alter  the 
structure from phase separated micro-composites to intercalated and exfoliated nanocomposites 
(Simha Martynková et al., 2007).
Commercial macromolecular compatibilizers (mainly maleic-anhydride-functionalized polyolefins) 
are most commonly used to improve the interfacial bonding between the fillers and the polymers 
whereas specifically synthesized functional homopolymers or copolymers have been utilized as 
well. In this article, we are reviewing a number of investigations, which studied the influence on 
the composite structure of various parameters like the compatilizer to inorganic ratio, the type and 
content  of  the  functional  groups  and  the  molecular  weight  of  the  functional  additive,  the 
miscibility between the matrix polymer and the compatibilizer, the kind of surfactants modifying 
the inorganic surface, the processing conditions, etc. (Valaskova et al., 2009).
29
It is a great challenge to characterize the structure and to manipulate the fabrication of polymer 
nanocomposites.  The  development  of  such  materials  is  still  largely  empirical  and  therefore, 
computer modelling and simulation will play an ever-increasing role in predicting and designing 
material  properties  and  guiding  such  experimental  work  as  synthesis  and  characterization. 
Computer modelling and simulation are especially useful in the thermodynamics and kinetics of 
the  formation  of  polymer  nanocomposites;  the  hierarchical  characteristics  of  the  structure; 
dynamics at the interface between nanoparticles and polymer matrix; the dependence of polymer 
rheological behavior and the molecular origins of the reinforcement mechanisms of nanoparticles 
in polymer nanocomposites. (Zeng et al., 2008) at first introduced some computational methods, 
covering from molecular scale (e.g., molecular dynamics, Monte Carlo), microscale (e.g., Brownian 
dynamics,  dissipative  particle  dynamics,  lattice  Boltzmann,  time-dependent  Ginzburg–Landau 
method,  dynamic  density  functional  theory  method)  to  mesoscale  and  macroscale  (e.g., 
micromechanics, equivalent-continuum and self-similar approaches, finite element method) and 
summarized the recent advances in the fundamental understanding of polymer nanocomposites 
reinforced by different types of nanofillers.
2.3.2 BIODEGRADABLE POLYMERS
Biodegradable polymers have innumerable uses in the biomedical field, particularly in the fields of 
tissue engineering and drug delivery (Lendlein et al., 2011; Tian et al., 2012). In order to be used as 
a therapeutic, the biodegradable polymer must meet several criteria: 
    1) be non-toxic in order to eliminate foreign body response; 
    2) the time it takes for the polymer to degrade is proportional to the time required for therapy; 
    3) the products resulting from biodegradation are not cytotoxic and are readily eliminated from 
the body;
    4) the material must be easily processed in order to tailor the mechanical properties for the  
required task; 
    5) be easily sterilized; 
    6) and have acceptable shelf life (Vroman et al., 2009; Middleton et al., 2000)
Biodegradable polymers are of great interest in the field of drug delivery. The great benefit of a  
biodegradable drug delivery system is the ability of the drug carrier to target the release of its  
payload to a  specific site in the body and then degrade into nontoxic  materials  that  are then 
eliminated from the body via  natural  metabolic  pathways (Caballero-George et al.,  2013).  The 
polymer  slowly  degrades  into  smaller  fragments,  releasing  a  natural  product,  and  there  is 
controlled ability to release a drug. The drug slowly releases as polymer degrades. Encapsulating 
the therapeutic in a polymer and adding targeting agents decreases the toxicity of the drug to  
healthy cells. 
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In  addition  to  tissue  engineering,  biodegradable  polymers  are  being  used  for  orthopedic 
applications, such as bone and joint replacement (Navarro et al.,  2008). A wide variety of non-
biodegradable  polymers  have  been used for  orthopedic  applications  including  silicone  rubber, 
polyethylene,  acrylic  resins,  polyurethane,  polypropylene,  and  polymethylmethacrylate.  The 
primary role of many of these polymers was to act as biocompatible cement in the fixation of 
prostheses and in the replacement of joints.
The first polymers to be used in biomedical applications, naturally-occurring polymers, far out-date 
the use of synthetic polymers which first appeared around the 1960s. They can be divided into the 
following  three  groups:  proteins  (e.g.  silk,  collagen,  soy,  and fibrin  gels),  polysaccharides  (e.g.  
chitin/chitosan, alginate and hyaluronic acid derivatives) and polynucleotides (e.g. DNA and RNA). 
The main advantage of natural polymers is their high degree of scaffold–tissue compatibility due to 
the positive biological recognition of their chemical make-up. However, the use of these polymers 
also carries the potential for inciting an immune response due to any impurities in the material  
gained during processing. Clinical applications require the use of medical grade materials and, in 
any instances where immunogenic fragments are detected within the material, it is imperative that 
they are removed  (Ozdil et al., 2014).
Synthetic  polymeric  biomaterials  may  not  always  come  as  cheaper  alternative  to  biological 
polymers due to less availability, however, they are much more easily reproducible and have a 
longer shelf-life and therefore are often more viable sources of polymeric biomaterials. Uniformity 
of microstructure, degradation rate and mechanical structure with large-scale production are the 
key advantages of these polymers. The most extensively used synthetic biomedical polymers is the  
family of linear aliphatic polyesters: polyvinyl alcohol (PVAL), poly(lactic acid), poly(glycolic acid), 
poly(hydroxybutyrate)  etc.  Numerous  combination  options  of  these  polymers,  both  with  each 
other and/or various other elements, generate a great assortment of composite scaffolds with 
varying chemical, structural and mechanical properties that can be suited to specific tissues and 
tasks.
POLYVINYL ACETATE (PVAC)
Polyvinyl acetate is an aliphatic rubbery synthetic polymer with the formula (C4H6O2)n. It belongs to 
the polyvinyl esters family with the general formula -[RCOOCHCH2]-. It is a type of thermoplastic.
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Figure 12. Polyvinyl acetate molecule.
PVAc is a vinyl polymer. Polyvinyl acetate is prepared by polymerization of vinyl acetate monomer  
(Fig.12) (free radical vinyl polymerization of the monomer vinyl acetate).
The degree of polymerization of poly(vinyl acetate) is typically 100 to 5000 while its ester groups 
are sensitive to base hydrolysis and will slowly convert PVAc into polyvinyl alcohol and acetic acid.
A number of microorganisms can degrade polyvinyl acetate; most commonly, damage is caused by 
filamentous fungi however there are also algae, yeasts, lichens and bacteria that have been shown 
to degrade polyvinyl acetate (Hoffman, 2012).
PVAc has been widely studied because of its excellent optical properties, biocompatibility, and few 
foreign-body reactions  in vivo (Yeum et al.,  2005),  therefore it  was selected for  the presented 
research as well as two following polymers.
POLYVINYL ALCOHOL (PVAL)
Polyvinyl  alcohol  (Fig.13)  is  a  water-soluble  synthetic  polymer.  It  has  the  idealized  formula 
[CH₂CH] . It is used in papermaking, textiles, and a variety of coatings. It is white and odorless. It isₙ  
sometimes supplied as beads or as solutions in water. Hydrogels being used as basic materials for  
manufacturing of wound dressings were invented in 1989 by (Rosiak et al., 1989). PVAL hydrogel is 
one  of  the  well-known  polymer  gel  that  due  to  its  good  biocompatibility,  has  been  used  in 
numerous biomedical applications, for example as implants, artificial organs, contact lenses, drug 
delivery devices, and also wound dressings in wounds management. There is a number of variety  
of methods for crosslinking PVAL chains in order to produce PVAL hydrogels, including electron 
beam irradiation, bulk mixing with crosslinking agents such as glutaraldehyde and also freezing–
thawing cyclic process (Kokabi et al., 2007).
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Figure 13. Polyvinyl acetate molecule.
POLYETHYLENE OXIDE (PEO)
Poly(ethylene glycol) (PEG), otherwise known as poly(oxyethylene) or poly(ethylene oxide) (PEO), is 
a  synthetic polyether  that  is  readily  available  in  a  range of  molecular  weights.  Materials  with 
Mw<100,000 are usually called PEGs, while higher molecular  weight polymers are classified as 
PEOs. These polymers are amphiphilic and soluble in water as well as in many organic solvents 
(e.g.,  methylene  chloride,  ethanol,  toluene,  acetone,  and  chloroform).  Low  molecular  weight 
(Mw<1,000) PEGs are viscous and colorless liquids, while higher molecular weight PEGs are waxy,  
white solids with melting points proportional to their molecular weights to an upper limit of about  
67 °C.
PEG (Fig.14) has been found to be nontoxic and is approved by the FDA for use as excipients or as a 
carrier in different pharmaceutical formulations, foods, and cosmetics. Most PEGs with Mw<1,000 
are  rapidly  removed  from  the  body  unaltered  with  clearance  rates  inversely  proportional  to 
polymer molecular weight. This property, combined with the availability of PEGs with a wide range  
of end-functions, contributes to the wide use of PEGs in biomedical research: drug delivery, tissue 
engineering scaffolds, surface functionalization, and many other applications. This section lists PEG 
and  PEO  polymers  classified  by  end-group  functions.  Note  that  methyl-terminated  PEGs  are 
classified as monofunctional PEGs.
Figure 14. Polyvinyl acetate molecule.
2.3.3  NANOFILLERS FOR NANOCOMPOSITES  - HYBRID NANOCLAYS
Clay minerals are the characteristic minerals of the earths near surface environments.  They form 
in soils and sediments, and by diagenetic and hydrothermal alteration of rocks.  Water is essential 
for  clay  mineral  formation and most  clay  minerals  are  described as  hydrous alumino silicates. 
Structurally, the clay minerals are composed of planes of cations, arranged in sheets, which may be  
tetrahedrally or octahedrally coordinated (with oxygen),  which in turn are arranged into layers 
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often described as 2:1 if they involve units composed of two tetrahedral and one octahedral sheet 
or 1:1 if they involve units of alternating tetrahedral and octahedral sheets.  Additionally some 2:1 
clay  minerals  have  interlayers  sites  between  successive  2:1  units  which  may  be  occupied  by 
interlayer cations, which are often hydrated.  The planar structure of clay minerals give rise to 
characteristic platy habit of many and to perfect cleavage, as seen for example in larger hand 
specimens of micas. 
 
Figure 15. Models of layers T-O, type 1:1 and layer T-O-T, type 2:1.
The classification of the phyllosilicate clay minerals is based collectively, on the features of layer  
type (1:1 or 2:1), the dioctahedral or trioctahedral character of the octahedral sheets (i.e. 2 out of 
3 or 3 out of 3 sites occupied), the magnitude of any net negative layer charge due to atomic 
substitutions, and the nature of the interlayer material.
The basis on which clay minerals are classified is shown below (see (Middleton et al., 2003) for a  
more detailed introduction to clay mineralogy).
  Table 3. Classification of clay minerals.
LAYER TYPE Layer charge (q) Group Subgroup Species (e.g.)
1:1 q≈0 Kaolin-Serpentine Kaolin Kaolinite
Serpentine Berthierine
2:1 q≈0      q≈1 Increasing 
layer 
charge
Pyrophyllite-talc Pyrophyllite Pyrophyllite
Talc Talc
Smectite (q≈0.2-0.6) Di-smectite Montmorillonite
Tri-smectite Saponite
Vermiculite  (q≈0.6-
0.9)
Di-vermiculite Di-vermiculite
Tri-vermiculite Tri-vermiculite
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Mica (q≈1.0) Di-mica Illite, Muscovite
Tri-mica Biotite
 q variable Chlorite Di-chlorite Sudoite
Tri-chlorite Chamosite
Sepiolite-Palygorskite Sepiolite Sepiolite
Palygorskite Palygorskite
Variable q variable Mixed-layer Di-mica-di-smectite Rectorite
Tri-chlorite-tri-
smectite
Corrensite
VERMICULITE
Vermiculite,  2:1 planar  hydrous phyllosilicate,  is  the mineral  with wide and unique application 
possibilities.  Nowadays  utilization  of  clays  in  nanocomposites  is  very  in  demand.  Natural  clay 
particles are hydrophilic and are sensitive to mechanical–chemical treatments. Their advantage is 
the nanobuilding units,  the silicate layers,  which can be obtained and used for  applications in 
nanotechnology.
The group of 2:1 phyllosilicates is composed of two types of sheet, tetrahedral (T) and octahedral  
(O). According to the AIPEA Nomenclature Committee (Guggenheim et al., 2007), tetrahedral sheet  
is composed of continuous two-dimensional corner-sharing tetrahedra TO4 involving three corners 
(basal oxygens) and the fourth corner (apical oxygen) pointing in any direction. The tetrahedral 
sheet  has  a  composition of  [T4O10]4– (T5Si41,  Al31,  Fe31,…)  in  which individual  TO4 are  linked by 
sharing basal oxygens with TO4 neighbors to form two-dimensional sheets where oxygens form an 
open hexagonal network. The apical oxygens form a corner of the octahedral coordination unit 
around larger octahedral cations. Tetrahedra are slightly distorted and the cavities bordered by six 
oxygens have ditrigonal symmetry (Radoslovich et al., 1962).
BENTONITE
Bentonite is absorbent aluminum phyllosilicate clay consisting mostly of montmorillonite. It was 
named by Wilbur C. Knight in 1898 after the Cretaceous Benton Shale near Rock River, Wyoming 
(Hosterman et al., 1992).
The different types of bentonite each are named after the respective dominant element, such as 
potassium  (K),  sodium  (Na),  calcium  (Ca),  and  aluminum  (Al).  Experts  debate  a  number  of  
nomenclatorial problems with the classification of bentonite clays. Bentonite usually forms from 
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weathering of volcanic ash, most often in the presence of water. However, the term bentonite, as 
well as similar clay called tonstein, has been used to describe clay beds of uncertain origin. 
For industrial purposes, two main classes of bentonite exist:  sodium and calcium bentonite. In  
stratigraphy and tephrochronology, completely devitrified (weathered volcanic glass) ash-fall beds 
are commonly referred to as K-bentonites when the dominant clay species is illite. In addition to 
montmorillonite and illite another common clay species that is sometimes dominant is kaolinite. 
Kaolinite-dominated clays are commonly referred to as tonsteins and are typically associated with 
coal.
MONTMORILLONITE
Montmorillonite is a very soft phyllosilicate group of minerals that form when they precipitate 
from water solution as microscopic crystals, known as clay. It is named after Montmorillonite in 
France. Montmorillonite, a member of the smectite group, is 2:1 clay, meaning that it has two 
tetrahedral sheets of silica sandwiching a central octahedral sheet of alumina. The particles are 
plate-shaped with an average diameter around 1 μm and a thickness of 9.6 nm; magnification of 
about 25,000 times, using an electron microscope, is required to "see" individual clay particles. 
Montmorillonite  is  a  subclass  of  smectite,  a  2:1  phyllosilicate  mineral  characterized  as  having 
greater  than  50%  octahedral  charge;  its  cation  exchange  capacity  is  due  to  isomorphous 
substitution of Mg for Al in the central alumina plane. The substitution of lower valence cations in  
such instances leaves the nearby oxygen atoms with a net negative charge that can attract cations.  
In  contrast,  beidellite  is  smectite  with  greater  than  50%  tetrahedral  charge  originating  from 
isomorphous substitution of Al for Si in the silica sheet.
The individual crystals of montmorillonite clay are not tightly bound hence water can intervene, 
causing the clay to swell. The water content of montmorillonite is variable and it increases greatly 
in volume when it absorbs water. Chemically, it is hydrated sodium calcium aluminium magnesium 
silicate hydroxide (Na,Ca)0.33(Al,Mg)2(Si4O10)(OH)2•nH2O.
2.3.4  ANTIMICROBIAL AGENTS
“The history of antimicrobials begins with the observations of Pasteur and Koch, who discovered  
that one type of bacteria could prevent the growth of another. They did not know at that time that  
the reason one bacterium failed to grow was that the other bacterium was producing an antibiotic.  
Technically, antibiotics are only those substances that are produced by one microorganism that kill,  
or prevent the growth, of another microorganism.
The discovery of antimicrobials like penicillin by Alexander Fleming and tetracycline paved the way  
for better health for millions around the world. Before penicillin became a viable medical treatment  
in the early 1940s, no true cure for gonorrhea, strep throat, or pneumonia existed. Patients with  
infected wounds often had to have a wounded limb removed, or face death from infection. Now,  
most of these infections can be cured easily with a short course of antimicrobials” [1].
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MECHANISMS OF ACTION OF ANTIMICROBIAL DRUGS
Selective Toxicity
Selective toxicity is the property of an ideal antimicrobial agent. Selective toxicity means that the 
drug is harmful to a parasite but not to the host. Usually the effect is relative rather absolute, i.e. a  
drug in a concentration tolerated by the host may damage an infecting microorganism. Selective 
toxicity may be a function of a specific receptor required for drug attachment, or it may depend on 
inhibition of biochemical events essential to the organism but not to the host. The mechanisms are  
discussed under four headings: (1) Inhibition of cell wall synthesis, (2) Inhibition of cell membrane 
function, (3) Inhibition of protein synthesis, and (4) Inhibition of nucleic acid synthesis.
Classification on mode of Action:
1. Inhibition of cell wall synthesis. Penicillins, cephalosporin, vancomycin, bacitracin, cycloserin are 
examples.
All  (3-Iactarn drugs  like  penicillins,  cephalosporins are  selective inhibitors  of  bacterial  cell  wall 
synthesis and therefore active against growing bacteria. Mechanism of action: Initial step is the 
binding of the drug to specific drug receptor PBPs (Penicillin- binding proteins) on bacteria. There  
are  3  to  6  PBPs  having  different  effects.  At  least  some  of  which  are  enzymes  involved  in 
transpeptidation (cross-linking) reactions. 
After attachment, peptidoglycan synthesis is inhibited as final transpeptidation is blocked. Then 
there occurs inactivation of an inhibitor of autolytic enzyme in the cell  wall.  This activates the 
autolytic enzymes in the cell wall that results in lysis resulting in bacterial death. 
Organisms with defective autolysin function are inhibited but not killed by l3dactam drugs, and 
they are said to be "tolerant".
The  Gram-positive  and  Gram-negative  bacteria  differ  in  susceptibility  to  penicillins  or 
cephalosporins on structural differences in their cell walls that decide binding, penetration, and 
activity of the drugs. The differences in cell wall are in the amount of peptidoglycan, presence of 
receptors and lipids, nature of cross-linking and activity of autolytic enzymes. Peptidoglycan layer 
of the cell wall is much thicker in Gram-positive than in Gram-negative bacteria.
Lack of toxicity of p-lactam drugs to animal cells is attributed to the absence of bacterial type cell  
wall with its peptidoglycan in animal cells.
Extended-spectrum P lactum (ESBLs) are enzymes that mediate resistance to extended-spectrum 
(third  generation)  cephalosporins  (e.g.,  ceftazidime,  cefotaxime,  and  ceftriaxone)  and 
monobactams (e.g., aztreonam) but do not affect cephamycins (e.g., cefoxitin and cefotetan) or 
carbapenems (e.g.,  meropenem or  imipenem).  Production of  ESBLs  can be screened by  broth 
microdilution and disk diffusion screening tests using selected antimicrobial agents.
2. Alteration of cell membrane function. 
Polymyxin, amphotericin B, imidazole are examples.
These  drugs  act  by  disruption  of  the  functional  integrity  of  the  cytoplasmic  membrane. 
Macromolecules  and  ions  escape  from  the  cell  causing  cell  damage  or  death.  Selective 
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chemotherapy is  possible as  the cytoplasmic  membrane of  bacteria  and fungi  has  a  structure 
different from that of animal cells.
3. Inhibition of protein synthesis. 
These  drugs  inhibit  protein  synthesis  in  bacteria.  Bacteria  have  70S  ribosomes,  whereas 
mammalian  cells  have  80S  ribosomes.  Subunits  of  each  type  of  ribosome,  their  chemical 
composition, and functional specifies differ. Thus a drug can inhibit protein synthesis in bacterial 
ribosomes but not in mammalian ribosomes.
4. Inhibition of nucleic acid synthesis. 
These drugs inhibit nucleic acid synthesis by different mechanisms.
The selected drugs for antimicrobial modification of silicate layers are listed in the following text.
CICLOPIROX OLAMINE
 
Figure 16. Ciclopirox olamine molecule.
In  contrast  to  the  azoles  and  other  antimycotic  drugs,  the  mechanism of  action  of  ciclopirox 
(Fig.16) is poorly understood (Niewerth et al., 2003). However, loss of function of certain catalase 
and peroxidase enzymes has been implicated as the mechanism of action, as well as various other 
components of cellular metabolism. 
In  a  study  conducted  to  further  elucidate  ciclopirox's  mechanism,  several  Saccharomyces 
cerevisiae mutants were screened and tested. Results from interpretation of the effects of both the 
drug treatment and mutation suggested that  ciclopirox may exert  its  effect  by disrupting DNA 
repair,  cell  division  signals  and  structures  (mitotic  spindles)  as  well  as  some  elements  of 
intracellular transport (Leem et al., 2003). It acts by inhibiting the membrane transfer system by 
interrupting  the  Na+  K+  ATPase  (Niewerth,  2003).   It  is  currently  being  investigated  as  an  
alternative treatment to ketoconazole for  seborrheic  dermatitis as it  suppresses growth of the 
yeast Malassezia furfur. Initial results show similar efficacy to ketoconazole with a relative increase 
in  subjective  symptom relief  due  to  its  inherent  anti-inflammatory  properties  (Ratnavel  et  al., 
2007).
Ciclopirox is considered a hydroxypyrimidine antifungal agent (Cappitelli et al., 2008).
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IMIDAZOLE
 
Figure 17. Imidazole molecule.
Imidazole is an organic compound with the formula C3N2H4. It is a white or colorless solid that is 
soluble in water, producing a mildly alkaline solution. In chemistry it is an aromatic heterocycle 
classified as a diazole and having non-adjacent nitrogen atoms.
Many natural products, especially alkaloids, contain the imidazole ring. These imidazoles share the 
1,3-C3N2 ring but feature varied substituents. This ring system is present in important biological 
building blocks,  such as  histidine and the related hormone histamine.  Many drugs  contain  an 
imidazole ring (Fig.17), such as certain antifungal drugs, the metronidazole series of antibiotics,  
and the sedative midazolam.
TRIHEXYLTETRADECYLPHOSPHONIUM BROMIDE
Figure 18. Trihexyltetradecylphosphonium bromide molecule.
Trihexyltetradecylphosphonium bromide (Fig.18) is a phosphonium-based ionic liquid that can be 
used as a recyclable reaction medium for Heck cross-coupling reactions. It can also be used to 
prepare supported liquid membranes (SLMs) for gas separation processes- The phosphonium salts 
are  proven  agent  for  antibacterial  effect.  They  were  studied  when  intercalated  into 
montmorillonite interlayer gallery (Wu et al., 2011).
TROLAMINE
Trolamine or Triethanolamine (Fig.19) is a viscous organic compound that is both a tertiary amine 
and a triol. A triol is a molecule with three alcohol groups. It is a colourless compound although 
samples may appear yellow because of impurities. 
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Figure 19. Trolamine molecule.
Triethanolamine is used primarily in making surfactants,  such as for emulsifier. It  is a common 
ingredient in formulations used for both industrial and consumer products. The triethanolamine 
neutralizes fatty acids, adjusts and buffers the pH, and solubilizes oils and other ingredients that 
are not completely soluble in water. Triethanolammonium salts in some cases are more soluble 
than salts of alkali metals that might be used otherwise, and results in less alkaline products than 
would  from using  alkali  metal  hydroxides  to  form the  salt.  Some common products  in  which 
triethanolamine is  found are  sunscreen lotions,  liquid  laundry detergents,  dishwashing liquids,  
general cleaners, hand sanitizers, polishes, metalworking fluids, paints, shaving cream and printing 
inks (Ashford et al., 2011). Trolamine is also used in cosmetics and medicine for example to treat 
the ear diseases and infections.
CLOTRIMAZOLE
Clotrimazole is an antifungal medication used to treat vaginal yeast infections, oral thrush, diaper  
rash,  pityriasis  versicolor,  and  types  of  ringworm  including  athlete's  foot  and  jock  itch  [2]. 
Ketoconazole  is  an  imidazole  antifungal  used  systemically  to  treat  candidiasis.  Clotrimazole. 
Clotrimazole is an imidazole antifungal used topically to treat candidiasis (Schaller, 1982).
Figure 20. Clotrimazole molecule.
Clotrimazole was discovered in 1969 [2] and nowadays is on the World Health Organization's List of 
Essential Medicines, the most effective and safe medicines needed in a health system [3].
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2.3.5 ANTITUMORAL DRUGS
There are numerous antitumorial drugs for gastroenterological cancer treatment. These drugs are 
used for specific cases in the system or other organs. Therefore the decision to include erlotinib to 
the study was for reason of wider applicability.
ERLOTINIB
In this research work EGFR inhibitor named Erlotinib (trade name “Tarceva”) was chosen.
Erlotinib (ERL) is a tyrosine kinase inhibitor. It works by helping to stop cancer cells from growing. 
This drug will be used in drug delivery system in study of nanocomposites with antibacterial and 
healing properties. Exact mechanism of antineoplastic activity is not fully elucidated. Appears to 
inhibit intracellular phosphorylation of tyrosine kinase associated with epidermal growth factor 
receptor (EGFR), which is expressed on the surface of normal and cancer cells.  Specificity with 
regard to other tyrosine kinase receptors not fully characterized. Within this research work it is 
important  to  consider  the  interactions  between  Erlotinib  antitumoral  drug  and  organic 
antibacterial  components,  which will  be  used for  biodegradable  coatings  inside  the  polymeric 
stents.
Erlotinib hydrochloride is approved to be used alone or with other drugs to treat: Non-small cell 
lung cancer (NSCLC) that is metastatic and has certain EGFR gene mutations. It may be used: As 
first-line therapy.
In  patients  on  maintenance therapy  or  whose  disease  has  gotten worse  after  treatment with 
chemotherapy.
The use of erlotinib hydrochloride to treat NSCLC that does not have the EGFR gene mutations is  
no longer FDA-approved.
Pancreatic cancer
It is used with gemcitabine hydrochloride in patients whose disease cannot be removed by surgery, 
is locally advanced, or has metastasized.
Erlotinib hydrochloride is also being studied for usage in the treatment of other types of cancer. In 
this study Erlotinib was used for molecular modeling, see chapter part 3.5.
In  the  experimental  study  I  used  Melphalan  (Sigma Aldrich)  and Chlorambucil  (Sigma Aldrich) 
antitumoral drugs, which were recommended by MUDr. Oldřich Urban, Ph.D. specifically for the 
bile  duct  types  of  cancer.  The  experiment  was  about  proper  preparation  of  polymeric 
nanocomposite samples with above mentioned antitumoral drugs and testing it on drug release 
with  HCT116  (Leeds)  cancer  cells  resulting  in  obtaining  the  IC50 -  the  half  maximal  inhibitory 
41
concentration  (a  measure  of  the  potency  of  a  substance  in  inhibiting  a  specific  biological  or 
biochemical function). At the moment of publication of this work the result is not obtained yet, but 
I recommend to continue in this research direction.
2.4. PROCESS OF BIOFILM ELIMINATION FROM SURFACE
Biofilm consists of:
- Microbes
- Extracellular polymers (EPS - polysaccarides, glycoproteins from microbes)
- Water (85-98%)
- Captured particles and other dissolved materials from the process stream
In the body, when biofilms form, they form a protective layer by which bacteria evade the immune 
system and antimicrobials.
At  present,  the  most  efficient  treatment  for  biofilm  infection  is  to  mechanically  remove  the  
infected area or body part. This is sometimes possible if the focus is a catheter, an implant, or an  
infected organ that is eligible for transplantation (Bjarnsholt et al., 2015).
So far the two main strategies for preventing or suppressing bacterial biofilm infections are (1) 
early  aggressive  antibiotic  treatment  before  the  biofilm  is  formed  or  (2)  chronic  suppressive 
antibiotic treatment when the biofilm is established if it cannot be removed physically.
2.4.1 MECHANO/PHYSICAL PROCESSES
Removal of Microorganisms from Surfaces (Wirtanen, 2015).
Technique Suitability Limitations
Swab, sponge & 
Gauze
Open surfaces, 
large areas or 
irregular surfaces
Need  suspension  which  will 
lower the sensitivity
Rinse Enclosed areas or 
small items
Dilution of the contamination 
is inevitable decreasing 
the sensitivity
Direct contact Critical spot areas 
with low 
contamination
Only small areas
can be examined
Table 4. Different ways of biofilm physical removal.
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2.4.2 CHEMICAL PROCESSES
When bacteria  form biofilms,  they  don’t  lump together  by  chance.  In  order  to form biofilms,  
bacteria need to communicate with each other (Jakobsen et al., 2012).
One  way to  disrupt  biofilm formation is  to  interrupt  bacterial  communication,  also  known as  
quorum sensing (QS) (Miller, 2001).
Quorum Sensing Inhibitors interrupt bacterial communication signals, which prevent them from 
aggregating.
For more information about natural biofilm disruptors see ANNEX.
2.5. CHARACTERIZATION TECHNIQUES AND MICROBIAL EFFECT TESTING
In order to study and characterize the prepared materials several analytical methods was selected.  
Each method provides important data which in the end shows the full picture about the material.
X-ray diffraction and FT Infrared spectroscopy methods were used for the structure evaluation and 
characterization of changes in the materials.
Several microscopy methods were employed to observe morphology of the nanofiller particles and 
the polymeric surface appearance.
2.5.1 X-RAY DIFFRACTION TECHNIQUE
X-ray diffraction (XRD) methods help to explain the structural changes during layered silicates 
intercalation and after incorporation to the polymeric matrix.
XRD relies on the dual wave/particle nature of X-rays to obtain information about the structure of  
crystalline materials. A primary use of the technique is the identification and characterization of  
compounds based on their diffraction pattern.
The dominant effect that occurs when an incident beam of monochromatic X-rays interacts with a 
target material is scattering of those X-rays from atoms within the target material. In materials with 
regular structure (i.e. crystalline), the scattered X-rays undergo constructive and destructive 
interference. This is the process of diffraction. The diffraction of X-rays by crystals is described by 
Bragg’s Law: nλ=2d sin θ,
where n is an integer, λ is the characteristic wavelength of the X-rays impinging on the crystallize 
sample, d is the interplanar spacing between rows of atoms, and θ is the angle of the X-ray beam 
with respect to these planes.
The directions of possible diffractions depend on the size and shape of the unit cell of the material.  
The intensities of the diffracted waves depend on the kind and arrangement of atoms in the crystal 
structure.  However,  most  materials  are  not  single  crystals,  but  are  composed  of  many  tiny 
crystallites in all possible orientations called a polycrystalline aggregate or powder. When a powder 
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with randomly oriented crystallites  is  placed in an X-ray beam, the beam will  see all  possible  
interatomic  planes.  If  the  experimental  angle  is  systematically  changed,  all  possible  diffraction 
peaks from the powder will be detected.
The parafocusing (or Bragg-Brentano) diffractometer is the most common geometry for diffraction 
instruments.
This geometry offers the advantages of high resolution and high beam intensity analysis at the cost 
of  very  precise  alignment  requirements  and  carefully  prepared  samples.  Additionally,  this 
geometry requires that the source-to-sample distance be constant and equal to the sample-to-
detector distance. Alignment errors often lead to difficulties in phase identification and improper 
quantification. A mis-positioned sample can lead to unacceptable specimen displacement errors. 
Sample  flatness,  roughness,  and positioning  constraints  preclude in-line  sample  measurement. 
Additionally,  traditional  XRD  systems  are  often  based  on  bulky  equipment  with  high  power 
requirements  as  well  as  employing  high  powered X-ray  sources  to  increase  X-ray  flux  on  the 
sample, therefore increasing the detected diffraction signals from the sample. These sources also 
have large excitation areas, which are often disadvantageous for the diffraction analysis of small 
samples or small sample features.
X-ray diffraction method as a tool for characterizing materials has a long history. It is one of the 
methods that  have  been successfully  used for  the determination of  the crystal  structure  of  a 
material. Although the X-ray diffraction method is a well-known technique, the method should be 
used after fully recognizing the differences from other evaluation methods and the feature of the 
method.  When  comparing  to  the  electron  beam  diffraction  method,  the  merits  of  the  X-ray 
diffraction method are as follows:
• Non-destructive and no special sample preparation is required.
•  Possible  to  be  preformed  in  atmosphere  and  under  a  special  atmosphere  such  as  a  high-
temperature or high-pressure condition.
• Possible to obtain information on the average structure in a relatively large area (mm to cm).
• Irradiation damages in organic materials are low.
• Possible to control the analysis depth by the incident angle onto the surface.
• Possible to characterize buried interface structure.
The last two points of merits are important for the evaluation of thin films (Inaba, 2008).
X-ray  diffraction  using  X-ray  optics  has  been  applied  to  many  different  types  of  applications 
including  thin  film  analysis,  sample  texture  evaluation,  monitoring  of  crystalline  phase  and 
structure, and investigation of sample stress and strain.
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Table 5. Characterization methods of thin film using X-ray diffractometer (Inaba, 2008).
2.5.2  FOURIER TRANSFORM INFRARED SPECTROSCOPY
Measurement techniques like attenuated total reflectance Fourier transform infrared spectroscopy 
(ATR) can for example be applied to characterize the composition of polymers.
FTIR Analysis or FTIR Spectroscopy is an analytical technique used to identify organic, polymeric, 
and, in some cases, inorganic materials. The FTIR analysis method uses infrared light to scan test  
samples and observe chemical properties.
A Fourier  Transform InfraRed (FT-IR)  Spectrometer  is  an instrument which acquires broadband 
Near InfraRed (NIR) to Far  InfraRed (FIR) spectra.  Unlike a dispersive instrument, i.e.  a grating 
monochromator or spectrograph, FTIR spectrometers collect all wavelengths simultaneously. This 
feature is called the Multiplex or Felgett Advantage.
FT-IR Spectrometers are often simply referred to as FTIRs. But for the purists, an FT-IR is a method 
of  obtaining  infrared  spectra  by  first  collecting  an  interferogram  of  a  sample  signal  using  an 
interferometer, and then performing a Fourier Transform (FT) on the interferogram to obtain the 
spectrum. An FT-IR spectrometer collects and digitizes the interferogram, performs the FT function, 
and displays the spectrum.
Infrared (IR) spectroscopy, the study of the interaction of infrared light with matter, is one of the 
most important techniques available for materials analysis. This chapter, will provide an overview 
of the principles of IR and Fourier transform infrared (FTIR) spectroscopy and sample preparation. 
FTIR  spectroscopy  has  been  extensively  used  in  both  qualitative  and  quantitative  analysis  of 
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nanofillers and their nanocomposites. In qualitative analyses, the nanofillers such as metal oxide 
nanoparticles,  carbonaceous  nanostructure,  clay,  nanofiller  synergy,  and  their  polymer 
nanocomposites will be characterized by FTIR spectroscopy. In quantitative analyses, FTIR will be 
employed to show the influence of a nanofiller on the properties of nanocomposite films through 
changes  in  the  band  intensity  of  FTIR  spectra.  The  effects  of  the  nanofillers  on  the  phase 
transformation of nanocomposite films is the topic to be researched (Jaleh et al., 2016). It is not 
always possible to unequivocally identify a compound by examining its IR spectrum alone. It is  
normal to use IR spectroscopy in conjunction with other techniques,  such as chromatographic 
methods, mass spectrometry, nuclear magnetic resonance (NMR) spectroscopy, and various other 
spectroscopic techniques.
The IR spectroscopy method is accurate, faster than chemical analysis, and reduces exposure to 
irritating, toxic, and corrosive chemicals. The polymer nanocomposites are a mixture of polymers 
and fillers. If two components are immiscible, the IR spectrum should be the sum of the spectra of  
the  two  components.  If  the  components  are  miscible,  there  is  the  possibility  of  chemical 
interactions  between the individual  polymer chains.  Such interactions may lead  to  differences 
between the spectra of the polymers in the nanocomposite and the pure components. Generally, 
wave number shifts and band broadening are seen as evidence of chemical interactions between 
the components in a composite and are indicative of miscibility.
The  IR  spectra  of  clay  minerals  (which  are  not  discussed  in  this  chapter)  show  well  defined 
absorption  bands  corresponding  to  fundamental  stretching  and  bending  vibrations  of  their 
structural units: for example, OH and Si-O groups. The stretching and bending vibrations of OH 
groups absorb in the 3700- 3500 and 950-650 cm-1 regions, respectively. The SiO stretching modes 
occur in the 1050-1000 cm-1, while the most intense bending bands appear in the 550-400 cm -1 
region.
2.5.3.DIFFERENTIAL SCANNING CALORIMETRY
Differential Scanning Calorimetry (DSC) is a technique used to investigate the response of polymers 
to heating. DSC can be used to study the melting of a crystalline polymer or the glass transition. 
The DSC set-up is composed of a measurement chamber and a computer. Two pans are heated in 
the measurement chamber. By measuring the heat change associated with the molecule’s thermal 
denaturation when heated at a constant rate. 
The higher the thermal transition midpoint (Tm), the more stable is the molecule. DSC measures 
the enthalpy (∆H) of  unfolding that  results  from heat-induced denaturation.  It  is  also used to 
determine the change in heat capacity (ΔCp) of denaturation. DSC can elucidate the factors that 
contribute  to  the  folding  and  stability  of  native  biomolecules.  These  include  hydrophobic 
interactions, hydrogen bonding, conformational entropy and the physical environment.
Macromolecules  and macromolecular  assemblies  (>5000  Daltons),  such  as  polymers,  proteins, 
sugars and lipids, can form well-defined structures that undergo thermally-induced conformational 
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changes.  These  structural  rearrangements  result  in  the  absorption  of  heat  caused  by  the 
redistribution of non-covalent bonds. Differential scanning calorimeters measure this heat uptake.
Figure 21. Demonstrative DSC measurement graph.
The enthalpy of protein unfolding is the area under the concentration-normalized DSC peak and 
has units of calories (or joules) per mole. In certain cases, thermodynamic models can be fitted to 
the data to obtain the Gibb's free energy (ΔG), the calorimetric enthalpy (ΔHcal),  the van't Hoff 
enthalpy (ΔHvH), the entropy (ΔS) and the change in the heat capacity (ΔCp) associated with the 
transition.
Figure 22. The meaning of DSC peaks.
Caloric effects observed in the DSC signal, e.g., the glass transition, crystallization and melting, as 
well as the pyrolytic decomposition and the combustion of the studied polymer samples, allow to 
see a detailed characterization. There are further advanced DSC tests like the determination of the  
oxidation induction time (OIT) which provides information about the thermal stability of polymers. 
It should be noted that in general two modes of DSC can be distinguished: heat flux versus power 
compensation; in this work, exclusively heat flux DSC was utilized which should not be put on a  
level with the simpler DTA (differential thermal analysis) method (Schindler et al., 2017).
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2.5.4 MORPHOLOGY AND TOPOGRAPHY ANALYSIS BY SCANNING ELECTRON AND 
ATOMIC FORCE MICROSCOPY 
Different microscopic techniques ranging from optical microscopy to electron microscopy (EM) and 
scanning  probe  microscopy  (SPM)  play  a  vital  role  in  the  characterization  of  polymer 
nanocomposite  morphology  on  different  length  scales.  The  unparalleled  contribution  of  the 
microscopic techniques (especially of electron microscopy and scanning force microscopy, SFM) in 
the development of nanocomposite science and technology can be realized by the fact that almost 
all of the scientific literatures devoted to PNCs make a direct or an indirect reference to the use of 
these  techniques.  Thus,  these  techniques  play  a  crucial  role  especially  in  the  optimization  of 
composite  properties  through  structural  characterization,  which  provide  direct  clues  not  only 
about the structure of the filler itself but also about the filler-matrix adhesion, filler distribution, 
and the impact of the filler on the morphology and properties of the embedding polymer matrix
Scanning Electron Microscopy (SEM) is a test process that scans a sample with an electron beam to 
produce a magnified image for  analysis.  The method is  also known as  SEM analysis  and SEM 
microscopy,  and is  used very effectively in microanalysis  and failure analysis  of  solid inorganic 
materials.  Electron  microscopy  is  performed  at  high  magnifications,  generates  high-resolution 
images and precisely measures very small features and objects.
Applications
The  signals  generated  during  SEM  analysis  produce  a  two-dimensional  image  and  reveal 
information about  the sample,  including external  morphology (texture),  chemical  composition, 
when used with the energy dispersive spectroscopy (EDS) feature, and orientation of materials  
making up the sample.
The  EDS component  of  the  system  is  applied  in  conjunction  with  SEM  analysis  to  determine 
elements in or on the surface of the sample for qualitative information. It also measures elemental  
composition for semi-quantitative results and identifies foreign substances that are not organic in 
nature and coatings on metal.
Figure 23. Electron beam interaction diagram.
Scanning Electron Microscopy uses a focused beam of high-energy electrons to generate a variety 
of signals at the surface of solid specimens (Fig. 23). In most SEM microscopy applications, data is 
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collected  over  a  selected  area  of  the  surface  of  the  sample  and  a  two-dimensional  image  is 
generated that displays spatial variations in properties including chemical characterization, texture 
and orientation of materials. The SEM is also capable of performing analyses of selected point  
locations on the sample. This approach is especially useful in qualitatively or semi-quantitatively  
determining chemical compositions, crystalline structure and crystal orientations.
The EDS detector separates the characteristic X-rays of different elements into an energy spectrum 
and  EDS system  software  is  used  to  analyze  the  energy  spectrum in  order  to  determine  the 
abundance of specific elements. A typical EDS spectrum is portrayed as a plot of X-ray counts vs. 
energy (in keV). Energy peaks correspond to the various elements in the sample. Energy Dispersive  
X-ray Spectroscopy can be used to find the chemical composition of materials down to a spot size 
of  a  few microns  and to  create  element composition maps  over  a  much broader  raster  area. 
Together, these capabilities provide fundamental compositional information for a wide variety of 
materials, including polymers and metals.
Electron  microscopy,  complemented  by  other  techniques,  has  played  important  role  in  the 
elucidation  of  morphology  and  structure-property  correlations  of  polymers  including 
homopolymers,  copolymers, blends,  and composite materials.  When employed vigilantly by an 
experienced microscopist with proper care during sample preparation, electron microscopy most 
reliably characterizes every detail concerned with the morphology of polymers on various length 
scales.  EM  identifies  the  structure  and  properties  of  specific  locations  of  polymers  and  the 
information is not restricted to the average values (Adhikari et al., 2009). 
Since the introduction of the Nobel Prize-winning scanning tunneling microscope (STM) and then 
the invention of  the atomic force microscopy (AFM) from the landmark publication by Binnig, 
Quate,  and  Gerber,  the  field  of  scanning  probe  microscopy  has  exploded  well  beyond  using 
interatomic  forces  to  image  topography  on  the  nanometer  scale.  The  ability  to  measure 
intermolecular forces and see atoms is scientifically tantalizing.
Topography imaging alone does not always provide the answers that researchers need and the 
surface topology often does not correlate to the material properties. For these reasons, advanced 
imaging modes have been developed to provide quantitative data on a variety of surfaces. Now, 
many material  properties can be determined with AFM techniques (Fig.  24),  including friction, 
electrical forces, capacitance, magnetic forces, conductivity, viscoelasticity, surface potential, and 
resistance.
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Figure 24. a) Example of AFM image including 3D profile and measurement of profile height, (b)  
Laser beam deflection on AFM cantilever when detected with position detector.
Analogous to how a Scanning Tunneling Microscope works, a sharp tip is raster-scanned over a 
surface using a feedback loop to adjust parameters needed to image a surface. Unlike Scanning 
Tunneling Microscopes, the Atomic Force Microscope does not need a conducting sample. Instead 
of using the quantum mechanical effect of tunneling, atomic forces are used to map the tip-sample 
interaction.
Often  referred  to  as  scanning  probe  microscopy  (SPM),  there  are  Atomic  Force  Microscopy 
techniques for  almost  any measurable  force  interaction – van der  Waals,  electrical,  magnetic,  
thermal. For some of the more specialized techniques, modified tips and software adjustments are 
needed.
In  addition to  Angstrom-level  positioning  and feedback  loop control,  there  are  2  components 
typically included in Atomic Force Microscopy: Deflection and Force Measurement.
Because the Atomic Force Microscope relies on the forces between the tip and sample,  these 
forces impact AFM imaging. The force is not measured directly, but calculated by measuring the 
deflection of the lever, knowing the stiffness of the cantilever (Bandyopadhyay et al., 2008).
50
2.5.5 MICROBIOLOGICAL TECHNIQUES.
MICROBIOLOGICAL MEDIA
Bacteria will grow on practically any source of organic food which provides carbon compounds to  
be respired for energy, and nitrogen compounds to be incorporated into proteins for growth. These 
substances are normally provided dissolved in water. However, in nature, bacteria can break down 
solid and insoluble substances by releasing enzymes into the substrate in which they are growing. 
These substances are thus broken down or digested to simpler substances and the process is called 
extracellular digestion because it takes place outside the bacterial cells.
The two normal media used in bacteriology are a clear soup-like liquid nutrient broth, usually in 
tubes, and nutrient agar, which is set into a jelly by the addition of a seaweed extract called agar,  
and when melted poured into glass or plastic Petri dishes - also known as "plates".
Figure 25. Disposable Petri dishes used for antimicrobial testing.
A standard carbon source is glucose, and nitrogen is often provided by peptones (partially digested 
proteins), or inorganic salts. Minerals and vitamins may also be provided, according to the growth 
requirements of the bacteria. Combinations of chemicals (buffers) may be used to keep the pH 
stable. Measured amounts of the concentrates are added to water, and dissolved to reconstitute 
the media.
Sometimes,  substances  are  mixed into  media,  in  order  to  suppress  growth  of  other  types  of  
bacteria. There are many such selective media. 
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STERILIZATION, ASEPTIC TECHNIQUES, INOCULATION, INCUBATION
These media must then be sterilised by heating in an autoclave (like a pressure cooker) at 121°C 
(pressure 1 bar or 15 lb/sq. in.) for 15 minutes, which kills all living organisms, including spores.
All apparatus used from this point onwards must be sterilised by heat (glassware - 160 °C for 2 hrs) 
or exposure to radiation.
Aseptic techniques must be used to reduce the likelihood of bacterial contamination. This usually 
involves disinfection of working areas, minimising possible access by bacteria from the air to 
exposed media, and use of flames to kill bacteria which might enter vessels as they are opened.
Bacteria may be introduced to the media (inoculated) by various means. Usually the bacteria e.g. 
from a drop in a heat-sterilised loop are spread on the surface of (ready set) agar. A similar 
technique is used with broth cultures. 
Sometimes bacteria in a liquid are introduced using a sterile pipette to the Petri dish before the 
(fairly cool) agar medium is poured on top ("pour plates").
Then the Petri dishes containing agar or tubes containing broth are incubated, i.e. put in a special 
apparatus at a fixed temperature (usually 37°C - human body temperature, for possible pathogens 
- or 25°C for bacteria from the environment). In schools, lower incubation temperatures are used 
in order to discourage the growth of potential pathogens.
Figure 26. Isolation of bacteria from a mixed culture. (A) isolation of pure culture and inoculation 
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needle  containing  a  loop,  (B)  pure  culture,  (C)(D)(E)  and  (F)  streaking  of  bacterial  culture  by 
different methods.
When growing bacteria, it is usual to invert the Petri dishes (Fig.26), so as to prevent condensation 
droplets from falling onto the surface of the agar. Petri dishes are often "sealed" at this stage to 
prevent people who handle them from contamination by bacteria, which will multiply greatly. It is 
normal to use 2 strips of adhesive tape from base to lid rather than attempt seal the circular edge 
of the Petri dish. This is to guard against the possibility of anaerobic organisms growing due to lack 
of air. However, it must be borne in mind that any drips from a partially sealed Petri dish are 
potential sources of infection. 
Cultures are usually examined after 24 hrs incubation.
Liquid media such as broth become cloudy if bacteria are present. This could be the result of only 
one bacterial cell originally entering the medium, then dividing repeatedly to produce millions! 
Bacteria on agar "plates" become visible as distinct circular colonies; each colony should represent 
an individual bacterial cell (or group) which has divided repeatedly but, being kept in one place, 
the resulting cells have accumulated to form a visible patch.
By an extension of this method using serial dilutions in sterilised liquids, the number of bacteria in 
a given amount of sample, e.g. food, can be calculated.
After use, bacterial cultures, etc. must be sterilised by the use of heat, before disposal.
AGAR AND BROTH DILUTION METHODS
Agar  dilution  and  broth  dilution  are  the  most  commonly  used  techniques  to  determine  the 
minimal concentration of antimicrobial agents that kill (bactericidal activity, MBC) or inhibit the 
growth (bacteriostatic activity, MIC) of microorganisms (Getzin et al., 2008).
In  the  agar  dilution  method,  different  concentrations  of  antimicrobial  agent,  either  by  direct 
addition, or by incorporation of the film forming solution or of finely divided active film sample, 
are added to non-selective agar medium before solidification. The test microorganisms are diluted 
to around log 7.0 CFU/mL and 1 to 2 are added to the plates in different spots (ca. 4.0 CFU per 
spot). 
There are several advantages of the agar dilution method including capacity to test different strains 
at once, easy detection of contamination and capacity to test opaque materials.
In the broth dilution assay,  an antimicrobial  is  added to a culture tube of  non-selective broth 
medium at  different  concentrations.  This  method can  be carried  out  by  using  glass  test  tube 
dilution (broth macrodilution) or microtiter plastic plates containing 96 wells (broth microdilution). 
Tubes are inoculated to contain approximately log 5.7 CFU/mL of the test microorganism.
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After incubation at 35 ± 2 °C, the tests  are examined and the MIC is determined generally by  
spectrophotometry.  Turbidity  of  the  medium  increases  with  microbial  growth,  therefore,  it  is 
necessary to build a calibration curve relating turbidity with microbial growth. The success of this 
method depends on the sensitivity of the device and the correct interpretation of results. Spec-
trophotometers generally require log 6.0–7.0 CFU/mL for detection (Piddock, 1990)
Below  these  concentrations,  the  lack  of  sensitivity  should  not  be  confused  with  absence  of 
microbial growth and, therefore, sampling for direct seeding is recommended.
Figure 27. Effect of an antimicrobial agent on the bacterial growth curve.
In order to study antimicrobial capacity of packaging films, they are immersed in 10 mL of Mueller 
Hinton broth prior to the inoculation of microorganism in exponential phase (when bacteria are 
more sensitive). Tubes are incubated under optimum conditions for the test microorganism from 
16 to 24 hours. Antimicrobial effect could be determined by spectro-photometry or by plating and 
counting.
Total inhibition of a pathogen or spoilage microorganism is not always required. An increased lag 
phase, especially under conditions of severe abuse, is often sufficient to protect the consumer. A 
description of  the effect of an antimicrobial  compound on the growth (or  death) kinetics of  a 
microorganism can be obtained through a growing curve such as the one shown in Fig.27. The 
release  of  the  antimicrobial  agent  from  the  active  package  results  in  an  increase  in  the 
concentration  to  which  the  microorganisms  are  exposed.  The  agent  concentration  reaches  a 
maximum and decreases  continuously  due to the loss  of  the agent  out  of  the package or  by 
dispersion in the food product, with a profile similar to that shown in Fig.27. The presence of an 
antimicrobial  agent  at  concentrations  above  the  MIC  results  in  a  delay  in  the  log  phase  and 
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lengthening of the lag phase, with the subsequent increase in the shelf life of the product. Once 
the agent concentration decreases below the MIC, microorganisms resume their growth. 
This method is similar  to the broth dilution assay but, in this case, the medium is sampled at  
appropriate times (e.g., 0, 2, 4, 8, 12, 24 and 48 hours) and the mber of viable microorganisms is 
determined by plating. Several responses of the test microorganism may be encountered in this  
type of analysis, including stationary phase growth level suppression, lag phase increase, decrease 
in the growth rate during log phase and lethality (Davidson et al., 1989). The disadvantage of these 
methods is that they are more tedious and longer than the agar diffusion one.
3. EXPERIMENTAL PART 
3.1. PREPARATION OF POLYMERIC NANOCOMPOSITE
This part is divided into 2 basic parts and so preparation of clay functional nanofillers and 
preparation polymeric nanocomposite films with nanofillers.
3.1.1. MATERIALS 
Three clay minerals were selected as carriers of antimicrobial/medicinal properties. Two of them 
are smectites (bentonite and montmorillonite); one is vermiculite so we could compare the effect 
of antimicrobial action and compounding efficiency such filler with polymeric matrix. 
Composition and crystalochemical formula are from literature (Valášková et al. 2008).
Five antimicrobial agents and different chemical compositions are shown in Table 6.
Following group of precursors are matrices for polymeric nanocomposite films. One of them is a 
monomer (vinyl acetate) and two of them are polymers (polyvinyl alcohol and polyethylen oxide).
Table 6. Chemicals and clays used during the experiment.
Component (abbreviation) Origin Formula  Properties
Vermiculite (VMT) Brazil (Mg,Fe,Al)3(Al,Si)4O10(OH)2·4(H2O) Fraction ≤40 
m
Bentonite (BEN) CZ (Ca, Na)(Al, Mg, Fe, Zn)2(Si, 
Al)4O10(OH)2 - xH2O 
Fraction ≤40 
m
Montmorillonite (MMT) Ivančice Ca0.24K0.06Na0.09Mg0.10(Al2.252Fe3+ 
0.54Mg0.90Ti0.04)(Si0.796Al0.04) O20(OH)4
Fraction ≤40 
m
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Imidazole (imi) Sigma 
Aldrich
C3H4N2 M =68.077 g/
mol
Trihexyltetradecylphosphonium 
bromide (bro)
Sigma 
Aldrich
[CH3(CH2)5]3P(Br)(CH2)13CH3 M = 563.76 g/
mol
Ciclopirox olamine (ciclo) Sigma 
Aldrich
C12H17NO2 · C2H7NO M = 268.35 g/
mol
Vinyl acetate (VA) Sigma 
Aldrich
CH3CO2CH=CH2 M = 86.09 
g/mol
Benzoyl peroxide (BP) Sigma 
Aldrich
(C6H5CO)2O2 M = 242.23 g/
mol
Trolamine (trol) Sigma 
Aldrich
C6H15NO3 M   =  
149.190 g/mol
Clotrimazole (clo) Sigma 
Aldrich
C22H17ClN2 M = 344.837 
g/mol
Polyethylene oxide (PEO) Sigma 
Aldrich
C2nH4n+2On+1 M = 18.02 + 
44.05n g/mol
Polyvinyl alcohol (PVAL) Sigma 
Aldrich
(C2H4O)x D = 1.19-1.31 
g/cm3
3.1.2.TECHNIQUES AND DEVICES 
Based on the state of a sample several methods were selected in order to characterize and observe 
the properties of materials.
Structural  analysis was performed using X-ray powder diffraction (XRD) analysis using the X-ray 
powder diffractometer Ultima IV Rigaku (Japan), operated at 40 kV and 40 mA (CuKα radiation).  
The XRD patterns of samples were measured at Bragg-Brentano arrangement, range 2-60°2θ, scan 
speed 2°/min. 
The infrared spectra (FTIR) were measured using single reflection ATR technique with a diamond 
crystal  on infrared spectrometer with Fourier  transformation Specifications of  the Nicolet iS50 
Infrared Spectrometer, Spectral range 7.800 - 350 cm-1;Ge / KBr beam splitter for the mid-infrared 
region; Software switchable 3 positions for detectors in the basic spectrometer; 0.09 cm -1 spectral 
resolution;  Integrated  ATR  diamond  attachment  to  allow  free  sample  space;  Module  for 
transmission measurement in KBr tablets;
Nicolet iN10 FTIR microscope, Thermo Scientific, USA, The IR spectra were measured in the form of 
spectral  maps  using  a  single  reflection ATR adapter  with germanium crystal  (16  scans,  8  cm -1 
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resolution) in the middle region of IR radiation (4000-600 cm -1) on an iN 10 FTIR microscope.
DSC131 evo - Differential Compensation Calorimetry DSC (-170 to 700°C), Temperature range from 
room  temperature  to  700°C;  Cryothermostat  for  cooling  -70°C  to  400°C;  Liquid  Nitrogen 
Accessories -170°C to 500 °C;  Scanning rate 0.01 to 100°C / min; Ar atmosphere (N2, O2, He);
Al cups 30,100 μl, Al2O3, (Pt) is set for both solid and liquid samples can be tested over a wide  
range  of  temperatures;  is  widely  used  to  determine  melting  temperatures,  glass  transitions, 
crystallization and degradation.
Light  microscope Olympus BX51 equipped with bright  field and dark  field observation mode , 
reflection and transmission mode, nosepiece 4x-40x , polarization filter. ¨
Scanning electron microscope FEI QUANTA 450 FEG, EDS Oxford elemental analysis (SED, BSED, 
GSED, vCD, SS-BSED, STEM detectors. 
Atomic Force Microscope  (AFM) Solver-Next, NT-MDT, possible to operate in contact, semi-contact 
and non-contact  modes;  contact mode (topography,  friction force mode,  modular  force mode, 
force  spectroscopy);  non-contact  mode  (percussion  topography,  phase  image  measurement, 
electrostatic force microscopy, magnetic force measurement, Kelvin probe microscopy, scanning 
capacitance microscopy); x-y-range: 100 x 100 micrometers, z-axis 10 micrometers; z-axis noise -  
0.04 nm, x, y-axis - 0.2 nm with capacitive sensors (i.e. with active linearization) switched on, 0.02  
nm in case of capacitive sensors off; both solid and powder samples can be analyzed.
3.1.3. METHODS FOR ORGANOCLAYS PREPARATION
The techniques for preparation of organoclays are based on wet intercalation with presumable 
cation exchange modification. 
Firstly, clay minerals were mixed together with antimicrobial organic compound. The solutions of 
individual agent were prepared as following:
Solution of 1.0 M Imidazole 1.5 g soluble in 20 ml distilled water and additional of 5 ml non-
aqueous ethanol; for 0.025 M Trihexyltetradecylphosphonium bromide 0.35 g soluble in 20 ml 
distilled water and addition of 5 ml non-aqueous ethanol; for 1.0 M ciclopirox olamine is 1.5 g 
ciclopirox in 20 ml water with addition of 5 ml non-aqueous ethanol.
Dry clays in amount of 4 g were mixed with 100 ml of solution. Then placing the suspension to 200 
ml flask magnetic stirring on magnet hotplate (80°C, 200 rpm) for 2 hours was done. After 2 hours 
mixture was centrifuged at 3500 rpm for 20 minutes and solid part – organoclay – was placed on 
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Petri dish, and then placed to the furnace on 80°C for 24 hours. After complete drying samples 
were grind in agate mortar to fine powder. 
3.1.4. METHODS FOR NANOCOMPOSITE PREPARATION
Experimental work related to preparation of self-standing film divides into two parts. First, the 
functional  filler  must  be  prepared  and  in  second  step  compounded  to  monomer  via  in  situ 
polymerization. 
Figure 28. Polymerization in situ – from monomer: nanofiller is with monomer in one reactor.
POLYMERIZATION OF VINYL ACETATE
Next  step is  polymerization  in situ with help of  an initiator.  The polymerization of  matrix  was 
carried out in a simple reaction setting: hot plate, lockable container. The mixture of monomer 
vinyl acetate and modified clay was in 10:1 weight ratio. The clay nanofiller was placed into a glass 
jar with a tight lid and mixed with vinyl acetate adding an initiator - benzoyl peroxide. The jar  
containing the mixture of monomer, initiator and nanoclay was ultrasonicated for 2 minutes or till  
no visible agglomerates of clay powder were observed. Further, the jar is heated on the hotplate to 
150°C (depending on the type of hotplate, the set temperatures may vary). The lid shouldn’t be 
closed too tight so it would be possible to open it after polymerization. 
The polymerization process takes approximately 15 minutes in case of vinyl acetate and chosen 
initiator, but the time may vary according to the settings and equipment. It may also depend on 
the  type  of  used  nanofiller.  The  samples  with  ciclopirox  olamine  polymerize  longer  than  15  
minutes (from 25 to 50 minutes).
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PREPARATION OF THE THIN FILM FROM POLYMERIZED VINYL ACETATE
During the observation of the heating jar the appearance of “bubbles” can be noticed as well as  
the increased viscosity of the liquid mixture, this means the polymerization started. Right after the 
starting of polymerization the liquid mixture in the jar rapidly becomes more and more viscous and 
needs to be removed from the heating plate as soon as possible. For preparation of thin films it is  
needed to have a neat smooth surface, therefore the Teflon material was chosen. Teflon was cut to 
10-12 cm2 pieces and fixed on the rotating plate. While it was slowly rotated, the polymerized 
mixture from the jar was poured to a Teflon piece forming a thin polymeric film on the surface.  
Teflon with the thin film was left overnight in the dry dark clean place without dust. Then the thin 
film was easily peeled from the Teflon.
PREPARATION OF THE THIN FILMS FROM POLYMERIC POWDERS
Both  polymers  (PEO and PVAL)  have been used as  polymeric  powders  with molecular  weight 
suitable for  solution in water (Fig.29).  The process included dissolving of  polymers in destilled 
water and compounding with filler nanoparticles. 
Figure 29. Polymeric water solutions of PEO and PVAl.
59
Figure 30. Re-polymerization– from polymer solution: nanofiller is mixed with diluted polymer.
The mixture of polymer and nanofiller was applied to a piece of Teflon or glass. After complete  
drying out it was peeled off from the material.
Figure 31. The visualization of the polymer solution preparation steps (Roy et al., 2017).
As  the polymerization process  is  over  the flask  with polymer should be taken away from the  
hotplate and a thin layer slowly applied on the piece of Teflon. The piece of Teflon should be 
attached to the rotating device and slowly rotated while the thin layer of polymer is applying on it.  
After the preparation place the Teflon with polymer to a dry dark space without dust for 24 hours.
After 24 hours the obtained dry polymeric thin film removes from the Teflon piece. The films were 
analyzed on XRD, AFM and FT IR to find out if the films are suitable for medical treatment usage.
As a result the polymeric thin films are presented on Fig.32 and Fig.33.
60
Figure 32. PEO + MMT/Imidazole macro photo. 
Figure 33. PVA + MMT macro photo.
 EXTRUSION METHOD OF THIN FILM PREPARATION
For  the  comparison  to  the  melt  techniques  several  samples  were  prepared  using  extrusion 
methods.
Polyethylene oxide nanocomposite was prepared using melt extrusion methods in UTB Zlin [4].  
The percentage of modified clay powder in the polymer was 1%. The amount of 8-9 grams of  
polymer was taken for  one sample,  so 0.08-0.09 grams of  clays  respectively.  The process was 
performed on the laboratory Extruder (Fig.34). The settings were on 200-210oC and 100 rpm in N2 
inert atmosphere. Filling the extruder with a sample powder takes approximately 5 minutes and 
then the extrusion process takes 4 minutes. If we consider the cleaning of the equipment as part of 
the process, we may say that preparation of one sample on laboratory extruder takes 45 minutes.
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Figure 34. Laboratory extruder UTB Zlin.
After extrusion the samples were pressed under the hydraulic press to create a thin film (Fig.35).
Figure 35. Melting hydraulic press UTB Zlin.
First, 2.7-3 grams of the sample from extruder should be placed to the special form (2mm) (Fig.36)  
and melted under a first type of hydraulic press on 200oC for 2 minutes.
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Figure 36. The form for creating thin films.
After melting the form is replaced to the second type of hydraulic press which provides cooling of  
sample during 10-15 minutes (Fig.37). 
Figure 37. Cooling hydraulic press UTB Zlin.
After all the manipulations such thin film was obtained (Fig.38)
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Figure 38. PEO thin film prepared via extrusion method in UTB Zlin.
The preparation by extrusion method takes much longer time, is much more energy-consuming 
and more dangerous regarding to the equipment using conditions if  we compare it  to the Re-
polymerization technique (in case of PEO). 
To obtain such a film (Fig.38) you will need 1,5-2 hours of time and three complex machines.
3.2. STRUCTURE CHARACTERIZATION AND DISCUSSION
3.2.1. X-RAY DIFFRACTION METHODS FOR STRUCTURAL CHANGES 
Organomodification of silicate layers is important for better compatibility with polymeric matrix.  
After  the  organoclay  has  swollen  in  the  solvent,  the  polymer  is  added  to  the  solution  and 
intercalates  between the clay layers.  The simple organic  modification of  the clay through ion-
exchange reactions is not always enough to achieve nanocomposite formation. This is because an 
ideal  compatibilization  agent  between  two  intrinsically  incompatible  components  should  have 
(combined  in  one  molecule)  parts  which  mix  thermodynamically  stable  and  easily  with  both 
components.
In our case the modification is multifunctional, the modified with organic matter silicate layer is  
simultaneously the active substance for antimicrobial activity.
XRD methods are important for evaluation of changes during intercalation process. 
For observation of changes several patterns of intercalated class and polymeric nanocomposites 
were selected. 
Since the molecules of selected active agent are relatively large, the intercalation is not always  
happening in the sense of inserted molecule / cation to the interlayer space of silicates.
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In case of vermiculite (Fig. 39) we are not observing big changes in position of the vermiculite basal  
peak. From original 1.419 nm organoform shifts to 1.291 nm indicating that interlayer water was 
removed and  large ciclopyroxolamine molecule was not intercalated, but adhered to the silicate 
layer. Later on the interlayer space of the polymeric nanocomposite remains slightly changed.
Figure  39.  XRD  patterns  of  VMT  changes,  original  vermiculite,  organovermiculite  with 
ciclopyroxolamine CP- vermiculite and polymeric nanocomposite  - CP-vermiculite + PVAc
Similar situation is repeating in case of bentonite (Figure 40 and 41). Original peak of bentonite (d 
= 1.21 nm) is similar to the one of organically modified with clotrimalzole (clo) and phosphonium  
cation (bro). 
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Figure 40. XRD patterns of BEN + clo sample (powder) with indicated interlayer spaces d.
Figure 41. XRD patterns of BEN + bro sample (powder) with indicated interlayer spaces d.
Next diffraction patterns (Fig. 42) compares two smectites – montmorillonite and bentonite – and 
their interaction with imidazole molecule. We can observe slightly more modified structure of the 
montmorillonite sample compared to bentonite where the interlayer space has changed from the 
indicating monolayer intercalation to the interlayer space.  
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Figure 42. X-ray diffraction patterns of clay particles modified with antimicrobial agent imidazole.
Comparing further (Fig. 43) the imidazole organoMMT and pure MMT embedded in PVAl, there is  
a clear disappearance of basal diffraction of the organoMMT. Therefore better incorporation of the 
filler can be presumed. 
Figure  43.  X-ray  diffraction  patterns  of  polymeric  nanofilm PVAL  +  MMT +  imi,  modified clay 
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+ MMT
particles MMT + imi and pure polymeric film PVAL.
Figure 44. X-ray diffraction patterns of 3 types of clay particles modified with antimicrobial agent 
ciclopirox olamine.
The changes observable after modification of all 3 clays with ciclopyroxolamine (Fig. 44) are rather 
small. Only in case of VMT we can see the peak at small angles, which can be partly intercalated 
VMT with large molecule of CPX.
Further  comparison  of  organovermiculite  VMT +  cpx  and  after  incorporation  to  the  polymers 
prepared via solution of polymers (Fig.45), we can see the decrease of crystalline matter in case of  
PVAl. Surprisingly the same method of preparation in case of PEO is not much affecting the filler.
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Figure 45. X-ray diffraction patterns of polymeric nanofilm PVAL + VMT + cpx, polymeric nanofilm 
PEO + VMT + cpx and clay particles modified with antimicrobial agent VMT + cpx (powder).
Figure  46.  X-ray  diffraction  patterns  of  polymeric  nanofilm  PEO  ind  +  VMT  +  trol,  polymeric 
nanofilm PVAL + VMT + trol and clay particles modified with antimicrobial agent VMT + trol.
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The molecule of trolamine was selected for similar application as ciclopyroxolamine, it is smaller 
and  therefore  smoother  and  more  predictable  in  interaction  with  other  components  of  the 
nanocomposite.  On Fig.46  a slight  change in  vermiculite  structure  is  visible,  the basal  peak  is 
divided to the non-intercalated part (1.102 nm) and an intercalated one (1.443 nm). After adding 
to the PVAl both peaks shift to higher numbers. In case of PEO (here the one from extruder is used  
– industrial  –ind)  the crystalline  character  of  polymer is  eliminating possibility  to observe low 
quantity content of VMT.  
Figure  47.  X-ray  diffraction  patterns  of  polymeric  nanofilm  containing  3  types  of  modifying  
antimicrobial agents.
Following example of PVAc (Fig.47) is showing well incorporated MMT nanofiller into the matrix.  
All 3 patterns are showing negligible peaks of remaining silicate basal diffraction. This should be  
caused  by in situ polymerization where the filler was sufficiently dispersed  in the conditions of 
polymerization. 
A  slightly  different  situation  is  in  case  of  vermiculite  (Fig.48),  where  the  basal  peak  is  still  
identifiable and the exfoliation of silicate layers is not as good as in case of montmorillonite.
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Figure  48.  X-ray  diffraction  patterns  of  polymeric  nanofilm  containing  3  types  of  modifying  
antimicrobial agents. 
3.2.2. FT INFRARED SPECTROSCOPY INTERACTION STUDY
Infrared  spectroscopy  was  used  for  observation  possible  creation  or  destruction  bonds  in 
polymeric nanocomposite. The submitted samples are showing the comparison of pure polymeric  
nanocomposite and the nanocomposite after stability testing. 
The  IR  spectra  of  clay  minerals  (which  are  not  discussed  in  this  chapter)  show  well  defined 
absorption  bands  corresponding  to  fundamental  stretching  and  bending  vibrations  of  their 
structural units: for example, OH and Si-O groups. The stretching and bending vibrations of OH 
groups absorb in the 3700-3500 and 950-650 cm-1 regions, respectively. The Si-O stretching modes 
occur in the 1050-1000 cm-1, while the most intense bending bands appear in the 550-400 cm -1 
region.
Infrared  spectroscopy  was  used  for  observation  possible  creation  or  destruction  bonds  in 
polymeric nanocomposite. The submitted samples are showing the comparison of pure polymeric  
nanocomposite and the nanocomposite after stability testing. The stability testing was performed 
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for PVAc samples because the other two types of nanocomposites are partially water soluble and  
relevancy for these tests would be not confrontable to PVAc polymer.
Figure 49. FTIR spectrum of PVAc + vermiculite + imidazole sample 
Characteristics bands of PVAc: C-H vibrations 2974 (asymmetric –CH3), 2926 (asymmetric –CH2), 
and 2852 cm-1(symmetric –CH2),  esters C=O at 1728 cm-1,  1222 and 1121 cm-1 C-O-C stretching 
vibrations and 1018 cm-1 CH-O vibrations, C-H deformation vibration at 1428 (-CH3), 1370 (-CH3), 
945 (C-CH3), and 706 cm-1.
The  band at  1560  cm-1 could  be  caused by  degradation of  PVAc  and  may correspond  to  the 
aromatic C-H vibrations.  Very intensive band at  3379 cm-1 corresponds to the O-H vibrations.  
It’s visible from the graphs that after the stability testing water is appearing on the 3500-3000 cm -1, 
the peaks on the right became slightly shorter because of crystalline degradation and on 1638 cm -1 
the water presence is visible. (Fig. 49)
STABILITY TESTING
Next step of experiment was to simulate the human liquids and their influence at polymeric film. 
For the first simple simulation it was decided to use Acetic acid (CH3COOH) with different pH (5.1; 
6.1; 7.0; 8.5; 9.8). The polymeric film was cut into small pieces and placed to the acetic acid 
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solutions. After couple of hours, it was dried out on 125°C. Some films had deformation but after 
repeating the experiment the film stayed holistic. After all, 45 unstrained samples were obtained. 
To make the analysis faster only higher pH samples were analysed on FT IR.
Figure 50. FTIR spectrum of PVAc + VMT + bro after stability testing at pH8.5.
Stability testing and changes observation had two levels. One was observation of changes in clay 
part of nanocomposite and second was the organic modification. 
From the Fig. 50 and 51 we can observe slight changes in case of water content, which might be 
related to higher hydrophilicity of vermiculite regarding to modifying organic matter for the 
individual cases. 
We can state here that PVAc nanocomposite will be more stable at pH 8.5 and modified with VMT 
+ phosphonium cation. 
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Figure 51. FTIR spectrum of PVAc + VMT + ciclo  after stability testing at pH9.8.
Following comparison of PVAc with MMT and bentonite modified with ciclopyrox olamine (Fig. 52 
and 53) is showing the difference in water content (band 3400 cm -1) and small deviations in 
organic matter (band 842 and 646 cm-1). Both changes are happening in case of bentonite, 
therefore we can presume lower stability of PVAc nanocomposite. 
Figure 52. FTIR spectrum of PVAc + MMT + ciclo, after stability testing at pH8.5.
Figure 53. FTIR spectrum of  PVAc + BEN + ciclo, after stability testing at pH9.8.
Last selected comparison is the most important, because it compares the sample before and after 
stability testing. The example was chosen so the highly water sensitive sample with 
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montmorillonite for the reason to observe the most visible changes during FTIR measurement.
The spectrum on the Fig. 54  look different, the way how the sample after testing is broadened 
predicts the disruption of integrity of the nanocomposite. The broad band of water 3401 cm  -1, that 
was not observable in original sample before testing is causing the lower intensities of other bands 
of the clay and organic matter as well. The organic matter bands are not changing the positions 
much but they are becoming less intensive. 
Generally we found that stability testing for PVAc based nanocomposites provides information 
about small changes in the structure and bonding interactions evaluated using FTIR spectroscopy 
methods. From this point of view we can consider the polymeric nanocomposite films stable. 
Figure 54 . Comparison of spectra PVAc + Montmorillonite + Imidazole and PVAc + Montmorillonite  
+ Imidazole (pH 8.5).
As a special technique for observation of individual phases dispergation FTIR microscopy was 
selected (Fig. 55), with possibility to observe  an area of sample in size of 500 x 500 microns of 
obtained spectra from selected points. Different colours in the map are showing related 
information regarding the spectrum below the map. The rule is: the more red in the scale, the 
better fitting phase. 
Polyvinyl acetate the red spectrum was selected as a phase for comparison, therefore the areas 
appearing red are the best fit to the reference spectrum. The areas in yellow are still partially 
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fitting the polymer but vary in certain bands. The least fitting areas are blue..
The presumption is that purely red areas are only PVAc and purely blue areas are inorganic, 
therefore related to clay particles. The other areas are their interfaces.
The measured map is showing well organized nanocomposite where individual phases are not 
mixed and are identifiable as individual, then there is some interfacial matter connecting the 
components of nanocomposite. The components distribution is good and the nanocomposite then 
can be considered as homogenous.     
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Figure 55. FTIR microscopy mapping of PVAc + VMT-ciclo sample.
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3.2.3. THERMAL BEHAVIOUR 
Thermal behaviour of prepared polymeric nanofilms was studied using DSC methods.
These methods allow to understand the gentle changes in the selected range of temperatures. 
For the purpose of human medicine application the range from -20°C to 400°C was selected. 
As  first  for  observation  we  selected  PEO  based  nanocomposites  sample  to  see  the  effect  of  
nanofiller in low temperature up to 50° C. We found that the highest number of changes is taking  
place in range from 10 to 40°C.  Each modifying agent  had different effect e.g.  bentonite with 
imidazole was reacting soon at about 23°C while pure montmorillonite only at 32° C. Generally  
non-modified fillers have changes around 30°C, but modified clays are starting thermal changes 
sooner. These changes are related to the decomposition of PEO. 
Figure 56. DSC spectra of samples PEO nanocomposites , range -20 to 50°C.
Second part of the analysed spectra is showing uniform changes (Fig. 57) regarding to 
temperature. There are differences in power of endothermic decomposition, pure vermiculite filler 
is the least active. 
The higher temperature changes are not mentioned because there was no reaction observed. 
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 Figure 57. DSC spectra of samples PEO nanocomposites, range 50 to 100°C.
Next analysed polymer was PVAc (Fig. 58) where the changes are taking place up to 350 °C. Most 
variable are samples up to 75°C and later at 135°C melting peak is appearing. Decomposition 
temperature is starting from 320°C intensively for sample with VMT ciclo and least performing for 
bentonite with imidazole.  
Figure 58. DSC spectra of samples PVAc nanocomposites, range -20 to 400°C.
Observing detail of the DSC spectra in range from -20 – 100°C (Fig. 59), we can see exo- and 
endothermal changes of evaporation at 20°C and oxidation starting at 25°C. Mild reaction is 
performing in MMT with clotrimazole while the most intensive changes are reported in VMT + ciclo 
nanofiller. 
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Figure 59. DSC spectra of samples PVAc nanocomposites, range -20 to 400°C.
Last analysed polymeric nanocomposite films were those based on polyvinyl alcohol. 
The range of observable changes was selected from -20 to 100°C where the changes are evaluable. 
First exothermal changes are observable at 20°C when the endothermal effect of oxidation starts 
to reach the maximum for some samples at the 25°C (pure non-modified clays) to temperature 
31°C (MMT-IMI, BEN-IMI). The endothermal decomposition takes place place at around 51°C, 
where the least observable is pure VMT and most visible is pure bentonite. 
Figure 60. DSC spectra of samples PVAl nanocomposites, range -20 to 100°C.
Generally the DSC analysis exposed the fact that organic modification changes the thermal 
properties of polymeric nanocomposite along with the oxidation and decomposition temperature, 
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which is very important for further applications. 
3.3. MORPHOLOGY CHARACTERIZATION AND DISCUSSION 
3.3.1. LIGHT MICROSCOPY OBSERVATION 
The light microscopy techniques are used here in two modes.  First,  the reflection mode, is to  
provide information about the surface conditions and to observe artefacts or anomalies of the 
process. Second mode is transmission mode, when the source light is going through the sample 
and the image shows the objects in the bulk of the sample if the matrix is transparent for the light. 
For our purpose transmission mode was applied to explore distribution of filler in matrix. 
Figure 61. LM image PVAc + Vermiculite + Ciclopirox olamine Bright Field, transmission mode.
Figure 62. LM image PVAc + Vermiculte + Cicloprox olamine Dark Field, transmission mode.
Two representative samples are given (Fig.61 and 62) to show that particles are distributed over 
the matrix but size and thickness is various. For the purpose of substrate as drug and antibacterial  
carrier such condition of filler distribution is sufficient.
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Figure 63.  LM image of PEO + MMT + IMI in dark field, reflection mode
Figure 64. LM image of PVAc + MMT + imi , dark field , reflection mode
In the figures 63 and 64 we used reflection mode to observe condition of the surface. We found 
that sample of nanocomposites based on PEO and PVAc are very different. It  is caused by the 
methods of preparation but also the type of the polymer. We can see 3D effect of the surface ,  
where  the  PEO  surface  is  much  rougher  than  PVAc  one.  Both  samples  have  very  uniform 
distribution of visible nanofiller particles.
3.3.2. ATOMIC FORCE MICROSCOPY
The atomic force microscopy is suitable tool to provide information from surface such as way of  
nano filler distribution in matrix or submicroscopic destruction of polymeric film. Selected samples 
of film were scanned for morphology of the surface. There was found rather regular distribution of 
clay particles along the film and no disruption of continuity of film after stability testing (Fig.65 and 
Fig.66).
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Figure 65. PVAc + Vermiculite/Ciclopirox olamine.
Figure 66. PVAc + Vermiculite/Imidazole.
3.3.3. SCANNING ELECTRON MICROSCOPY (SEM)
SEM methods were used to observe nanofiller morphology and size of the particles.
The  organoclays  prepared  from  vermiculites  are  exposing  the  exfoliated  particles  with  visible 
layered structure (Fig. 67-68). The nanoparticles were observed using 2 detectors and the back 
scattered detectors -BSE- the particles being compact without extra matter (e.g. organic matter) on 
the surface.
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Figure 67. SEM image of organovermiculite VMT + ciclo acquired with SE detector.
Figure 68. SEM image of organovermiculite VMT + ciclo acquired with BSE detector.
Comparing bentonite particles (Fig. 69) to the vermiculite particles we can see a very different 
morphology.  Particles are compact  without  layered character.  They appear to be covered with 
smaller particles or other matter and they look agglomerated and larger.
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Figure 69.  SEM image of organobentonite ben  ciclo acquired with SE detector.
Similar  situation  seems  to  be  in  case  of  montmorillonite  with  imidazole.  Particles  are  less 
agglomerated than in case of bentonite but still  hardly visible layered character presents large 
particle more then 5 microns.
Figure 70. SEM image of MMT -imidazole particle acquired with SE detector.
To evaluate morphology of the film SEM was used. It was found that particles of clays are generally 
embedded into polymeric matrix and they have various micrometric sizes. The elemental analysis  
is also presented according to chosen point on the SEM image. It shows the presence of organoclay 
nanoparticles  in  the polymeric  matrix.  Some of  polymeric  films are  partially  disrupted due to  
preparation technique,  where small  grows are  visible  on surface (Fig.71).  Disruption also took 
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place while the beam was intense on a not enough stable sample, it left small holes in some of  
polymeric samples. (Fig. 72).
Figure 71. SEM of PVAc VMT trol sample with elemental analysis.
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Figure 72. SEM of PEO MMT ciclo sample with elemental analysis.
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Figure 73. SEM of PVAc bent ciclo sample with elemental analysis.
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Figure 74. Detail of polymeric surface with VMT particle using SEM.
In  the  detailed  image  of  polymeric  surface  (Fig.74)  we  can  observe  the  various  types  of  
incorporation of the nanofillers to the matrix. Not all particles are inside the polymer and some of  
them  are  not  covered  with  it.  This  might  be  beneficial  for  antimicrobial  activity  and  further 
application since the exposed surface of particles is most active and gradual uncovering immersed 
particles will provide long term functional surface
In the  Fig.75 we can observe relatively rough and lamellar surface of PVAc nanocomposite. This 
could be cause by casting method of preparation of such polymeric nanocomposite. The nanofiller 
particles  are  also  visible  as  lighter  below  the  lamellas.  Such  surface  provides  nanostructured 
morphology – individual  lamellas  can be estimated as submicron wide,  and can play a  role in 
antimicrobial activity as patterned surface.
Figure 75. Detail of PVAc nanocomposite surface – the morphology after casting method.
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Figure 76. Image of SEM of PVAl + MMT + ciclo 2.5Kx surface.
This image can be compared to the one of LM (Fig.63), where uneven surface was observed. SEM 
revealed the granular-like morphology.
3.4. ANTIMICROBIAL TESTING
Further  analysis  was  about  proving  the  antimicrobial  properties  of  obtained  polymeric 
nanocomposites. For that purpose several microbiological procedures with the bacteria related to 
bile duct microflora were done.
Commercial solid Műller-Hinton and Schaedler agar plates for the cultivation of bacteria without 
any additional modifications were used.
Staphylococcus aureus 3953, Enterococcus faecalis 4224 and Pseudomonas aeruginosa 1960 were 
acquired from the Czech Collection of Microorganisms (Czech Republic). Clostridium difficilae was 
isolated from an incognito patient at the hospital in Ostrava.
Incubation of bacteria was conducted in Biological thermostat BT 120M at 37°C. Incubation of C.  
difficilae was conducted in Whitley A35 anaerobic workstation (Don Whitley Scientific) at  37°C 
under anaerobic conditions.
Agar plates were inoculated with bacterial strains. Squares of samples (approx. 1 cm2) were placed 
on the inoculated plates and incubated.  After 24 hours visual  evaluation was performed.  This 
experimental setup is based on disc diffusion test which is commonly used for test with antibiotics. 
In this case diffusion of active substance (nanocomposite filler) was not occurred and therefore 
zones of inhibition are not as evident as in case of disc diffusion test and thus cannot be measured.  
Antibacterial effect of tested materials it is thus limited to the immediate surroundings.
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Table 7. ++ - “strong” antibacterial activity, + - antibacterial activity, - no-antibacterial activity.
3.4.1 ANTIMICROBIAL TESTING OF 36 POLYMERIC NANOCOMPOSITES.
36 different nanocomposites were prepared, see Table 8.
Table 8. Prepared samples, see the abbreviations in Table 7.
Preparation of media:
“Sobrecapa” (overlayer)
Destilled water 250 ml
Dibasic phosphate 2.5 g
Monobasic phosphate 1 g
Agar 2 g
Brain heart infusion (BHI) 3.75 g
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BHAT 
Destilled water 250 ml
Dibasic phosphate 2.5 g
Monobasic phosphate 1.075 g
Agar 4.25 g
BHI 9.25 g
Two solutions were prepared, the overlayer solution was put to a microwave until boiling. After 
microwave the solution had to be moved to glass test-tubes, 6 ml each tube, closed with test-tube 
caps and moved to autoclave for 15 minutes on 121°C together with the BHAT solution.
After autoclave BHAT was moved to water bath to cool down to 55°C and then the liquid was 
rapidly poured to Petri dishes, which were closed overnight on 37°C.
The overlayer method showed following results (Table 9):
Polyvinyl alcohol Staphylococcus  
aureus
Enterococcus (S47) Escherichia coli
MMT + clo ++ - -
MMT + imi ++ - -
MMT + ciclo ++ - +
MMT - - -
Polyvinyl acetate Staphylococcus  
aureus
Enterococcus (S47) Escherichia coli
MMT + clo + - +
MMT + imi + - -
MMT + ciclo - - -
MMT + - -
Polyethylene oxide Staphylococcus  
aureus
Enterococcus (S47) Escherichia coli
MMT + clo +++ - -
MMT + imi - - -
MMT + ciclo +++ ++ ++
MMT - - -
Table 9. Overlayer method antimicrobial ativity on different samples.
+++ - high inhibition 
++ - good inhibition
+ - small inhibition
- - no inhibition
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The streaking method:
Polyvinyl acetate Staphylococcus  
aureus
Enterococcus (S47) Escherichia coli
Bent + ciclo + - -
VMT + ciclo + - -
MMT + ciclo +- - -
MMT + - -
Table 10. The inhibition of various polymeric nanocomposite samples via streaking method.
Figure 77. The visible inhibition on a Petri dish.
3.4.2 BILE SALTS SIMULATION
In parallel we tried to perform bile salts based medium to try to grow the bacteria in human-like 
gastrointestinal conditions.
To obtain the pH 3.0 and pH 2.0 in 150ml BHI we used Chlorhydric acid (37% HCl). The agar did not 
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solidify.
So we decided to replace HCl with citric buffer. For 200ml 6.02 g of Sodium Citrate and 0.867 g of 
citric acid. We used this buffer instead of destilled water for the medium (BHbroth 3.7 g, agar 1.8 g, 
100ml pH 2 buffer; BHbroth 3.7 g, agar 1.8 g, 100ml pH 3 buffer).
To see if bacteria will grow on such medium we prepared 4 Petri dishes - 2 with 1.8% BHI bile salts 
and 2 with 3.6% bile salts. Next day all 4 plates were with grown bacteria on it.
      Bact. strain 
Sample
Staphylococcus  
aureus
Enterococcus (S47) Escherichia coli
PEO VMT ciclo +++ +++ +++ ++ +++ +++
PVAc MMT ciclo +- +- - - - -
PVAl bent ciclo +++ +++ +++ ++ +++ +++
PVAl bent - - - - - -
The concentration of 
bile salts in the BHI
1.8% bile 
salts
3.6% bile 
salts
1.8% bile 
salts
3.6% bile 
salts
1.8% bile 
salts
3.6% bile 
salts
      Bact. strain
Sample
Staphylococcus  
aureus
Enterococcus (S47) Escherichia coli
PVAl VMT ciclo +++ +++ +++ + +++ +
PEO MMT ciclo +++ +++ +++ +++ +++ +++
PVAc bent ciclo +- +- - - - +-
PEO VMT - - - - - -
The concentration of 
bile salts in the BHI
1.8% bile 
salts
3.6% bile 
salts
1.8% bile 
salts
3.6% bile 
salts
1.8% bile 
salts
3.6% bile 
salts
       Bact. strain
Sample
Staphylococcus  
aureus
Enterococcus (S47) Escherichia coli
PVAc VMT ciclo +- +- - - - -
PVAl MMT ciclo +++ +++ +++ ++ +++ ++
PEO bent ciclo +++ +++ +++ +++ +++ +++
PVAc MMT +- +- - - - -
The concentration of 
bile salts in the BHI
1.8% bile 
salts
3.6% bile 
salts
1.8% bile 
salts
3.6% bile 
salts
1.8% bile 
salts
3.6% bile 
salts
Table 11. Antimicrobial activity in the bile salts experiment.
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3.4.3. BIOFILM FORMATION
Figure 78. The microtiter well plate for growing biofilms. C - control (no sample, only biofilm), T1 - 
PEO VMT ciclo, T2 - PEO MMT ciclo, T3 - PEO BEN ciclo, T4 - PVAc VMT ciclo, T5 - PVAc MMT ciclo, 
T6 - PVAc BEN ciclo, T7 - PVAl VMT ciclo, T8 - PVAl MMT ciclo, T9 - PVAL BEN ciclo. Note: the wells 
duplicate.
For growing of biofilms the microtiter well plates were used (Fig.78). 4.9 mcL of TSB with bacteria 
and without bacteria were put to the wells and left overnight.
After overnight the liquid from wells was removed without disturbing of biofilm. Then it was 
washed with 200 mcL NaCl (0.85%) and the liquid was again removed. Then 200 mcL of  Milli-Q 
water was poured and after that the polymeric nanocomposite thin film samples were placed to 
the wells. The microtiter plates went to incubate on 37°C for 1 hour.
After an hour the polymers and water are removed from wells. Wash with 200 mcL NaCl, remove. 
Next step is dilution. The diluted solution drops put to Petri dishes (Fig.79)
95
Figure 79. The dilution technique.
As visible on Fig.78. the wells duplicate, C, C, T1, T1 etc.
We used both (1) and (2) on separate plates for clear results in order to exclude the mistakes.
T1 – PEO + VMT + ciclo
T2 – PEO + MMT + ciclo
T3 – PEO + BEN + ciclo
T4 – PVAc + VMT + ciclo
T5 – PVAc + MMT + ciclo
T6 – PVAc + MMT + ciclo
T7 – PVAl + VMT + ciclo
T8 – PVAl + MMT + ciclo
T9 – PVAl + BEN + ciclo
(1) 1 hour S. aureus S47 E.coli
control 8/11/7 (-5) 1/1/3 (-5) 7/8/10 (-5)
T1 11/14/13 (-5) 20/14/7 (-4) 1/2/2 (-5)
T2 5/3/10 (-5) 12/4/7 (-5) 1/5/5 (-5)
T3 4/2/5 (-5) 2/14/8 (-4) 4/6/9 (-5)
T4 4/6/5 (-5) 10/7/6 (-5) 11/8/6 (-5)
T5 8/5/3 (-5) 10/5/7 (-5) 9/7/7 (-5)
T6 7/8/12 (-5) 4/2/2 (-4) 6/6/3 (-5)
T7 3/5/4 (-5) 4/9/1 (-4) 4/4/2 (-5)
T8 2/3/3 (-5) 8/6/5 (-4) 9/8/1 (-5)
T9 5/2/4 (-3) 14/21/16 (-4) 9/9/10 (-5)
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(2) 1 hour S. aureus S47 E.coli
control 9/9/6 (-5) 4/4/5 (-5) 6/7/7 (-5)
T1 8/13/12 (-5) 4/9/9 (-5) 3/4/3 (-5)
T2 7/5/3 (-5) 8/6/10 (-4) 15/6/27 (-4)
T3 6/6/5 (-5) 7/4/5 (-5) 6/4/7 (-5)
T4 1/6/5 (-5) 17/16/13 (-4) 3/5/3 (-5)
T5 4/4/3 (-5) 7/12/8 (-4) 5/6/1 (-5)
T6 10/10/9 (-5) 6/13/10 (-4) 5/6/5 (-5)
T7 13/12/8 (-5) 17/23/17 (-4) 3/6/8 (-5)
T8 6/8/3 (-5) 10/11/13 (-4) 11/9/10 (-5)
T9 3/4/2 (-5) 19/15/18 (-4) 3/2/3 (-5)
Table 12. Dilution test results after 1 hour.
Now the same test but after 24 hours of incubation:
(1) 24 hours S. aureus S47 E.coli
control 15/17/15 (-5) 25/20/18 (-5) 9/14/12 (-5)
T1 15/15/11 (-5) 15/13/11 (-5) 24/31/27 (-4)
T2 11/17/14 (-5) 8/9/5 (-5) 12/26/19 (-4)
T3 31/40/31 (-5) 5/11/11 (-5) 10/9/13 (-5)
T4 10/17/10 (-5) 19/16/18 (-5) 18/22/25 (-5)
T5 12/8/14 (-5) 8/9/8 (-5) 17/24/17 (-5)
T6 10/12/9 (-5) 17/13/17 (-5) 9/8/4 (-5)
T7 15/19/19 (-5) 28/25/31 (-5) 14/14/19 (-5)
T8 33/27/23 (-5) 6/6/6 (-6) 24/16/23 (-5)
T9 23/31/32 (-5) 24/19/20 (-5) 14/14/8 (-5)
(2) 24 hours S. aureus S47 E.coli
control 9/17/11 (-5) 15/12/14 (-5) 13/15/8 (-5)
T1 5/5/11 (-4) 6/4/7 (-5) 4/5/5 (-4)
T2 21/33/33 (-4) 9/13/12 (-5) 4/8/5 (-4)
T3 33/47/43 (-4) 16/16/20 (-5) 11/13/14 (-5)
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T4 5/11/14 (-5) 21/18/21 (-5) 15/21/15 (-5)
T5 14/13/12 (-5) 9/16/11 (-5) 8/15/15 (-5)
T6 19/22/21 (-5) 10/19/19 (-5) 30/30/27 (-5)
T7 29/27/26 (-4) 32/24/28 (-5) 4/7/4 (-6)
T8 9/11/9 (-5) 15/20/17 (-5) 19/21/25 (-5)
T9 20/24/17 (-5) 31/23/38 (-5) 7/8/6 (-5)
Table 13. Dilution test results after 24 hours.
Obtained results allow to count CFU/ml and to view it by time (Fig.80).
Colony-Forming Unit (CFU) is a unit used to estimate the number of viable bacteria or fungal cells 
in a sample. Viable is defined as the ability to multiply via binary fission under the controlled 
conditions. Counting with colony-forming units requires culturing the microbes and counts only 
viable cells, in contrast with microscopic examination which counts all cells, living or dead. The 
visual appearance of a colony in a cell culture requires significant growth, and when counting 
colonies it is uncertain if the colony arose from one cell or a group of cells. Expressing results as 
colony-forming units reflects this uncertainty. 
Figure 80. CFU/ml by time. Red – S47, blue – S.aureus, green – E.coli.
It shows how 3 different biofilms react on 9 types of samples in 1 hour and in 24 hours of 
inhibition. There is no visible difference between  (1) and (2) duplicates, which means that the 
conditions were similar. As I performed this test only once, further tests are recommended to 
obtain full picture. Next attempt was to grow biofilm in an improved way with the liquid flow 
simulation to imitate the flow of bile liquids.
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 VIEWING OF BIOFILM GROWTH
Another way of biofilm growing simulation was performed on a non-standard equipment, which 
was self-assembled by Dr. Ben Johnson (Leeds). The description of the experiment and the scheme 
of the system (Fig.81-82) is shown below.
Figure 81. The improvised self-assembled by Dr. Ben Johnson biofilm growing system.
Microfluidic chip:
All microfluidic devices used are initially produced using photolithography techniques. A usable 
device is then produced by PDMS casting on the silicon master. The devices are then cut, hole 
punched, and bound to 50 × 22 mm 0.13 – 0.17 mm glass cover slips via oxygen plasma bonding.
Bacterial growth system
The full system (shown below) comprises of 2 100mL Duran bottle reservoirs, one for media and 
another for the effluent / waste. Each bottle is fitted with a 0.22 μm filter to allow pressure 
equalisation and flow through the system. Flow through the system is supplied by a single MP6 
piezo pump which is controlled via an external controller, a flow rate of 50 μL / min is used to 
mimic in vivo flow rates.
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Figure 82. Biofilm growth system scheme.
The tubing directly into and out of the pump has an internal diameter of 1.3 mm, with all other 
tubing sections measuring 1.6 mm ID, luer lock male / female fittings are used throughout to 
connect parts. Inoculation is performed using a 1 mL syringe via a stop cock which automatically 
shuts off to avoid back-flow or leakages. 
Standard Operating Procedure
1. Stock culture preparation
a. Autoclave (250 - 500 mL) of BHI broth and allow to cool to room temperature.
b. Check growth on primary plate culture is pure based on colony morphology
c. If no evidence of contamination exists on the primary culture plate, touch three 
separate colonies of test bacteria a sterile disposable loop and inoculate 100mL of 
BHI broth, incubate this at 37°C overnight, simultaneously inoculate an LB-agar 
plate to check sterility of the broth culture. 
d. Using bacterial broth, produce 100 x 1mL aliquots, flash freeze, and store at -80°C 
freezer for future use.
2. Leak check and sterilisation
a. All apparatus is autoclaved, movable parts (2- and 3-way valves, stop cocks) are 
soaked in 70% ethanol.
b. All autoclaved apparatus is transported to a category II safety cabinet and irradiated 
with UV light for 30 minutes. 
c. Within the safety cabinet, the whole system is assembled, all valves are opened and 
the whole system is flushed with 70% ethanol followed by air (Note: this could flush 
also the polymeric sample), this can be done using syringes by hand or the micro 
pump, though these must first be primed.
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d. The system is then primed with sterilised MilliQ water.
e. Arrange all valves in the way media flow path is unimpeded, check the inoculation 
stop cock is closed.
f. Fill the media reservoir with autoclaved BHI broth.
g. Transport the system to the incubator set to 37°C and set the pump to flow 
overnight at 300 Hz and 30-40 Vpp – configure beforehand for 50 μL min-1 flow rate.
h. Once complete, move system to safety cabinet and check for leaks. A sample of the 
media can be taken to inoculate a horse-blood agar and sabouraud agar plate using 
sterile plastic loop (Fig.83). Immediately replace the waste media reservoir lid after 
this step.
i.
Figure 83. The loops diagram.
3. System inoculation with S.aureus
a. 5 mL of S.aureus UAMS-1 cell culture is drawn into a 5 mL syringe, then connected 
to the system via the bacterial inlet tubing stop cock.
b. The 2-way valve prior to the device’s media channel connection is closed to prevent 
back-flow.
c. The bacterial stop cock is opened and the inoculum is carefully injected slowly to 
flow the bacteria towards the waste media outlet.
d. Once inoculated, transfer the system back to the incubator set at 37°C for one hour 
to allow the bacteria to settle and properly adhere to the surfaces within the 
chamber, do not remove the syringe at this point.
4. Media flow and overnight growth
a. Open the 2-way valve prior to the chip media connection and set the micro pump to 
flow fresh media overnight at a flow rate of 50 μL min-1
b. Check the system in the morning next day to ensure no leaks have occurred.
5. Staining and use of reagent loop
a. Prepare a solution of live/dead stain (DMAO and EthD-III in 0.85% NaCl solution).
b. Reagent loop can be primed with 0.85% NaCl buffer as the diagram below shows 
(Fig.82), removal of bubbles and air pockets is essential to maintain biofilm integrity. 
c. Once the loop is primed with the live/dead stain, introduce using a micro pump set 
to 50 μL min-1 ensuring the 3-way valve connecting to the system blocks back-flow 
of stain up the media tubing.
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d. Once the system has been stained, stop the pump flow and leave the system in the 
dark for 20 minutes.
e. Give the system one final flush through at the same flow rate with buffer only to 
remove unused dye, prepare for transport to confocal microscope. 
Figure 84. Sample of media on horse blood agar result.
Transporting the system to the confocal microscope requires placement of the system into a sealed 
container to avoid spills and an accidental disconnections during transit.
The confocal microscope Leica DMi8 viewing.
Top chamber - polymer+clay
Central chamber - control w/o sample
Bottom chamber - polymer+clay+antimicrobial agent (Fig.85)
Figure 85. Biofilm growth device scheme, the samples are shown in red color.
Magnification 2.5x of the device is shown on Fig.86-88:
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Figure 86. Top chamber 2.5x.
Figure 87. Central chamber 2.5x.
Figure 88. Bottom chamber 2.5x.
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Figure 89. Top part 10x magnification. Green (left) - live cells, red (right) - dead cells.
Figure 90. Bottom part 10x magnification. Green (left) - live cells, red (right) - dead cells.
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Figure 91. Top, Central and Bottom parts with 40x magnification. The location: in the middle of a 
chamber. Green (left) - live cells, red (right) - dead cells.
Figure 92. Top and Bottom parts 100x magnification. The sample residuals. Green (left) - live cells, 
red (right) - dead cells.
The experiment was done only once and only one sample was tested. For the next experiment like 
this in case of water soluble polymeric matrices I would recommend to pay attention about 
flushing the system with liquids like media or ethanol as it may affect the presence of polymeric 
matrix, dissolve it to some extent and flush out some of antimicrobial agent, too. 
This experiment showed that the samples are affecting the S.aureus biofilm growth by lowering it 
(Fig.93-95), more data is needed for deeper understanding. I would recommend to try out other 
polymers and other antimicrobials as well as different bacterial strain biofilm simulation or even a 
simulation of a multimicrobial biofilm which is more likely to meet in the human gastrointestinal 
conditions.
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The green filter is supposed to show us the living cells and the red filter - dead cells.
Figure 93. Top part with clay 40x magnification, location - . Green (left) - live 
cells, red (right) - dead cells.
Figure 94. Central part control 40x magnification, location - . Green (left) - live 
cells, red (right) - dead cells.
Figure 95. Bottom part 40x magnification, location - . Green (left) - live cells, red 
(right) - dead cells.
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It is well visible that there is significantly more bacteria, as it is without any sample, so based on 
that we can presume that the sample is functional against given biofilm in these improvised “in-
body conditions”.
3.5. MOLECULAR MODELING
The  selected  for  the  molecular  modeling  study  biodegradable  triblock  copolymers  are 
polycaprolactone  polyethylene  glycol  polycaprolactone  (PCL-PEG-PCL)  and  polycaprolactone 
polyglycolic  acid  polycaprolactone  (PCL-PGA-PCL)  and  as  an  antitumoral  drug,  Erlotinib  was 
chosen.  By means of  molecular  modeling,  it  was  found out  that  for  both matrices  the bigger 
amount of drug is a reason of growing of cohesive energy density (CED). It means that the system 
is more stable when there is a greater amount of drug. In the case of polyethylene glycol (PEG) and 
polyglycolic acid (PGA) the data was obtained, that together with generally lower values of CED for  
PCL-PEG-PCL matrix the findings may indicate stronger interaction between Erlotinib and PGA than 
with PEG. This work was a first step for understanding the advantages and disadvantages of various 
materials for medical using. See the full study  (Hlaváč et al., 2018).
Figure  96.  Mutual  positions  of  ERL  and  hydrophilic  parts  of  copolymers  at  the  end  of  MD 
simulation  performed  under  periodic  boundary  conditions.  a  PCL/PEG_1;  d  PCL/PGA_1.  ERL 
molecules are displayed in green, PEG blue and PGA violet colors. PCL parts of chains are omitted 
for clarity.
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4. CONCLUSION 
The  presented  work  is  focused  on  materials  suitable  for  medical  applications,  where  rapidly 
growing microbial biofilm is one of the serious dangers for life and health of a human being. Since  
the range of the materials and applications in the field of prosthetics inserted in the body is large, 
this work specializes only on one type of medical devices like gastroenterological stents applied in 
case of the extracted or damaged bile duct.
The goal of this research was to develop a functional antimicrobial polymer coating, which might 
be used afterwards for medical applications such as biliary stents. The research in this field focuses 
on study and optimization of polymeric stent material in accordance with the conditions in the 
body.
A number of materials was prepared experimentally, characterized by various techniques, viewed 
by  molecular  modeling  and  tested  in  “in-body  conditions”.  In  my  opinion,  based  on  multiple 
experiments, the purpose to find the most effective combinations of nanocomposite contents is  
achieved.  
• Modified natural  clay minerals  were proved to be  functional antimicrobial  agents when 
embedded to polymeric matrix.
• Modification of the clay doesn’t have to reach the intercalated level.  Partly-intercalated 
montmorillonite  layers  and  surface-modified  vermiculites  had  positive  impact  on 
incorporation of nanofiller to the polymeric matrix and antimicrobial properties. 
• Selection of  the 3 polymeric  matrices was done based on the known clinical  facts  and 
literature recherche. Based on experimental knowledge modifying compounds – imidazole, 
clotrimazole and ciclopyroxol amine  - were selected for natural clay minerals.
• At the time of elaboration of the dissertation work unique technique for preparation and 
casting thin polymeric films was established. Tailoring the conditions of the nanocomposite 
preparation a well dispersed nanocomposite with self-standing properties was possible to 
fabricate.  
• To prove the functionality in the application for inner coating of polymeric bile duct stent 
several testing methods were proposed. Nanocomposite testing for stability was performed 
in  base  pH  conditions,  as  known  for  bile  fluid.  The  stability  was  proved  for  PVAc 
nanocomposites.
• Functionality of the polymeric nanocomposite is synergic and the individual’s properties are 
multiplied with strength of  other component.  The best combinations of  the researched 
materials are vermiculite and montmorillonite particles modified with ciclopirox olamine,  
imidazole and clotrimazole. Regarding polymeric matrices all 3 selected matrices showed 
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their applicability for medical purposes.
In further research I recommend to focus on above mentioned combinations of components in 
nanocomposite  and  continue  to  develop  an  antitumoral  polymeric  nanocomposite  with 
antimicrobial properties. 
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ANNEX
Natural biofilm disruptors:
 Foods
     Linoleic acid (omega-6)  (Magesh et al., 2013)     (Pandit et al., 2015)
    Oleic Acid/Olive Oil  (Pandit, 2015)
     Honey (Merckoll et al., 2009)  
     Propolis (candida biofilm) (Garg et al., 2013) 
    Apple Cider Vinegar (Bjarnsholt, 2015)- physiologically tolerable concentrations of 
acetic acid can completely eradicate bacteria in mature biofilms in vitro.
     Caprylic acid (G+,-, fungal) (Rosenblatt et al., 2015)
     Stevia (Theophilus et al., 2015)
     Xylitol (Alves et al., 2013)
     Garlic (Shuford et al., 2005)
     Manuka (Lu et al., 2014)
     Ginger (Kim et al., 2013) (G+,-)
     Cranberry (Reid et al., 2001)
Non-Herbal Biofilm Disruptors
 Chitosan (Silva-Dias et al., 2014), (Magesh, 2013)
  N-acetylcysteine (NAC) (Dinicola et al., 2014) 
   Lactoferrin (Alves, 2013), (Ammons et al., 2013)
   EDTA (Banin et al., 2006) – EDTA likely exerts antimicrobial activity by chelating 
magnesium and calcium – minerals which are necessary for growth and membrane 
stability and may also display anti-biofilm activity by reducing biofilm material (EPS) 
production and/or enhancing the detachment of bacterial cells from the biofilm. 
Magnesium, calcium, iron, zinc, and manganese appear to stabilize the biofilm matrix of a 
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variety of organisms by enhancing structural integrity through electrostatic interactions 
that serve to cross-link the matrix (Cavaliere et al., 2014) 
 Zinc (Wu et al., 2013)
  Iron (Musk et al., 2005)
  Manganese (Cavaliere, 2014)
  Monolaurin (Goc et al., 2015)
   Colloidal Silver (Rajiv et al., 2015)
   Zeolite (Acidithiobacillus thiooxidans) (Haile et al., 2010)
   L Reuteri (Hurdle et al., 2009)
   Citrates (Bosma et al., 2010)– Calcium Citrate, Magnesium Citrate
   Norspermidine (found in chlorella) (Böttcher et al., 2013)
Enzymes
     Trypsin (Chaignon et al., 2007)
     Serratiopeptidase (Mecikoglu et al., 2006)
     Nattokinase (Zapotoczna et al., 2015)
Herbal Biofilm Disruptors
     Andrographis (Murugan et al., 2011)
     Curcumin (Zorofchian Moghadamtousi et al., 2014)
     Berberine (Wang et al., 2009)
    Cinnamon/Cinnamaldehyde (Liu et al., 2015) and Cinnamon essential oil (Kavanaugh et 
al., 2012)
     Black cumin oil/Thymoquinone (Chaieb et al., 2011)
     Boswellia (Raja et al., 2011)
     Vanilla
     Ginkgo
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     Oregano Oil (carvacrol+thymol) (Nostro et al., 2007)
     Quercetin (Pejin et al., 2015)
     Apigenin, Naringenin, Kaempferol  (Vikram et al., 2010)
     St John’s Wort (Sarkisian et al., 2012)
     Baicalein (Goc, 2015)
     Neem (Garg, 2013),  (Harjai et al., 2013)
     Gentian violet (Wang et al., 2008)
     Mangosteen (streptococcus) (Nguyen et al., 2014) 
     Alfalfa (Sadowska et al., 2014)
     Eugenol (Liu, 2015)  (Magesh, 2013) (Kavanaugh, 2012) – found in Tulsi, clove essential 
oil and cinnamon essential oil
Other
     Farnesol (Alves, 2013)
     D-Amino Acids (Böttcher, 2013)
     Reserpine (Magesh, 2013)
      Rifampicin (Jacqueline et al., 2014)
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